VNUE (VNUE) S-1/A14 Jul 22IPO registration (amended)Financial data

Company Profile

Cover

Cover	3 Months Ended
Cover	Mar. 31, 2022
Cover [Abstract]
Document Type	S-1/A
Amendment Flag	true
Amendment Description	Amendment No. 3
Entity Registrant Name	VNUE, INC.
Entity Central Index Key	0001376804
Entity Tax Identification Number	98-0543851
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	104 West 29th Street,
Entity Address, Address Line Two	11th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10001
City Area Code	833
Local Phone Number	937-5493
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash	$ 60,458	$ 36,958	$ 4,458
Prepaid expenses		464,336	100,000
Total current assets	160,458	501,294	104,458
Total assets	13,087,127	501,294	104,458
Current liabilities:
Accounts payable and accrued expenses		923,061	2,372,072
Shares to be issued	1,192,290	247,707	247,707
Accrued payroll-officers	231,750	233,750	209,750
Advances from former officer		720	720
Advances from officer	10,000	10,000	0
Notes payable	1,142,542	869,157	34,000
Deferred revenue	857,326	74,225	74,225
Convertible notes payable	638,714	635,714	1,956,922
Purchase liability	7,979,984	300,000	300,000
Derivative liability		0	3,156,582
Total current liabilities	14,755,555	3,294,334	8,351,979
Total liabilities	14,755,555	3,294,334	8,351,979
Commitments and Contingencies	0	0	0
Stockholders’ Deficit
Preferred stock, par value $0.0001: 20,000,000 shares authorized; 4,250,579 issued and outstanding as of December 31, 2021 and December 31, 2020		425	413
Common stock, par value $0.0001, 2,000,000,000 shares authorized; 1,411,799,497 and 1,211,495,162 shares issued and outstanding, as of December 31, 2021, and December 31, 2020, respectively	145,925	141,177	121,149
Additional paid-in capital	13,213,622	10,900,652	8,386,593
Accumulated deficit	(15,028,400)	(13,835,294)	(16,755,676)
Total stockholders’ deficit		(2,793,040)	(8,247,522)	$ (4,025,052)
Total Liabilities and Stockholders’ Deficit	$ 13,087,127	$ 501,294	$ 104,458

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Preferred stock, shares par value		$ 0.0001	$ 0.0001
Preferred stock, shares authorized		20,000,000	20,000,000
Preferred stock, shares issued		4,250,579	4,250,579
Preferred stock, shares outstanding		4,250,579	4,250,579
Common stock, shares par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	2,000,000,000	2,000,000,000	2,000,000,000
Common stock, shares issued	1,459,256,460	1,411,799,497	1,211,495,162
Common stock, shares outstanding	1,459,256,460	1,411,799,497	1,211,495,162

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Revenues - related party	$ 100,476	$ 22,474
Direct costs of revenue	153,181	8,509
Gross margin (loss)	(52,705)	13,965
Operating expenses:
General and administrative expense	932,134	601,022
Total costs and expenses	932,134	601,022
Operating loss	(984,839)	(587,058)
Other income (expense), net
Change in fair value of derivative liability	3,156,582	(2,234,073)
Other income	1,172,789
Loss on the extinguishment of debt	(80,227)	(263,609)
Financing costs	(343,923)	(1,469,037)
Other income (expense), net	3,905,221	(3,966,719)
Net income (loss)	$ 2,920,382	$ (4,553,777)
Net loss per common share - basic and diluted	$ 0	$ 0
Weighted average common shares outstanding:
Basic and diluted	1,300,621,328	1,135,193,463

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2019	$ 413	$ 77,088	$ 8,099,346	$ (12,201,899)	$ (4,025,052)
Beginning Balance, shares at Dec. 31, 2019	4,126,776	770,883,602
Shares issued on conversion of notes payable
Conversion of convertible notes to common shares		$ 42,257	277,817		320,074
Conversion of convertible notes to common shares, shares		422,572,017
Shares issued for services		$ 50	100		100
Shares issued for services, shares		500,000
Shares issued to pay interest expense		$ 1,754	9,330		11,084
Shares issued to pay interest expense, shares		17,539,543
Net income				(4,553,777)	(4,553,777)
Ending balance, value at Dec. 31, 2020	$ 413	$ 121,149	8,386,593	(16,755,676)	(8,247,522)
Ending Balance, shares at Dec. 31, 2020	4,126,776	1,211,495,162
Beneficial conversion feature of convertible notes			111,765		111,765
Net income				1,991,101	1,991,101
Ending Balance, shares at Mar. 31, 2021		1,211,495,162
Beginning balance, value at Dec. 31, 2020	$ 413	$ 121,149	8,386,593	(16,755,676)	(8,247,522)
Beginning Balance, shares at Dec. 31, 2020	4,126,776	1,211,495,162
Beneficial conversion feature of convertible notes			111,765		111,765
Shares issued upon conversion of convertible notes payable	$ 12	$ 7,520	1,273,991		1,281,523
Shares issued upon conversion of convertible notes payable, shares	123,803	75,195,174
Private placement of common shares		$ 12,509	1,128,303		1,140,812
Net income				2,920,382	2,920,382
Ending balance, value at Dec. 31, 2021	$ 425	$ 141,177	10,900,652	(13,835,294)	(2,793,040)
Ending Balance, shares at Dec. 31, 2021	4,250,579	1,411,779,497
Shares issued for services		$ 600	$ 56,200		56,800
Shares issued for services, shares		6,000,000
Net income				$ (1,193,106)	$ (1,193,106)
Ending Balance, shares at Mar. 31, 2022		1,459,256,460

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Cash Flows From Operating Activities:
Net income (loss)	$ 2,920,382	$ (4,553,777)
Adjustments to reconcile net income to net cash provided by (used for) operating activities
Change in the fair value of derivatives	(3,156,582)	2,234,073
Loss on the extinguishment of debt	80,227
Shares issued for financing costs	0	253,194
Shares issued for services		100
Amortization of debt discount	111,765	78,013
Changes in operating assets and liabilities
Prepaid expenses	(364,337)	(100,000)
Accounts payable and accrued interest	(1,045,767)	1,395,179
Deferred revenue	0	74,225
Accrued payroll officers	24,000	100,500
Net cash used in operating activities	(1,430,312)	(518,493)
Cash Flows From Investing Activities:	0	0
Cash Flows From Financing Activities:
Advances from officers	10,000
Payments on promissory note	(22,000)
Payment of convertible note		(45,134)
Procceds from the private placement of common shares	1,140,812
Proceeds from the issuance of convertible notes	334,000	515,989
Net cash provided by investing activities	1,462,812	470,855
Net Decrease In Cash	32,501	(47,638)
Cash At The Beginning Of The Period	4,458	52,096
Cash At The End Of The Period	36,958	4,458
Supplemental disclosure of cash flow information:
Cash paid for interest	0	0
Cash paid for income taxes	0	0
Supplemental disclosure of non-cash information:
Common shares issued upon conversion of notes payable and accrued interest	$ 0	$ 0

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2020		Dec. 31, 2019
Current assets:
Prepaid expense	$ 100,000
Total current assets	104,458
Total assets	104,458
Current liabilities:
Accrued liabilities	466,801
Accrued interest	2,372,072
Notes payable	34,000
Convertible notes	1,956,922
Total current liabilities	8,351,979
Total liabilities	8,351,979
Commitments and contingencies	0
Stockholders’ Equity:
Preferred Stock value	413
Common stock, $0.0001 par value, 20,000,000 shares authorized, 972,614 shares issued and outstanding as of December 31, 2020 and 2019	121,149
Additional paid in capital	8,386,593
Accumulated deficit	(16,755,676)
Total stockholders’ equity	(8,247,521)
Total liabilities and equity	104,458
Stage It Corp [Member]
Current assets:
Cash and cash equivalents	281,003		$ 88,457
Prepaid expense			1,288
Other assets	127,874		118,795
Total current assets	408,877		208,540
Fixed assets -net	62,912
Total assets	471,789		208,540
Current liabilities:
Accounts payable	427,087		223,795
Accrued liabilities	1,785,861		699,914
Accrued interest	650,654		502,916
Accrued interest -related party	767,715		617,891
Notes payable	179,000	[1]	179,000
Convertible notes -related party	547,500		547,500
Convertible notes	315,000		315,000
Derivative liability	2,404,981		2,099,025
Total current liabilities	7,077,798		5,185,041
Total liabilities	7,077,798		5,185,041
Commitments and contingencies
Stockholders’ Equity:
Common stock, $0.0001 par value, 20,000,000 shares authorized, 972,614 shares issued and outstanding as of December 31, 2020 and 2019	97		97
Additional paid in capital	3,963,327		3,963,327
Accumulated deficit	(10,569,502)		(8,939,994)
Total stockholders’ equity	(6,606,009)		(4,976,502)
Total liabilities and equity	471,789		208,540
Stage It Corp [Member] \| Preferred Stock A [Member]
Stockholders’ Equity:
Preferred Stock value	4		4
Stage It Corp [Member] \| Preferred Stock A 1 [Member]
Stockholders’ Equity:
Preferred Stock value	25		25
Stage It Corp [Member] \| Preferred Stock A 2 [Member]
Stockholders’ Equity:
Preferred Stock value	20		20
Stage It Corp [Member] \| Preferred Stock A 3 [Member]
Stockholders’ Equity:
Preferred Stock value	$ 20		$ 20

[1]Notes payable are comprised of a note for $179,000 at 15% interest in both period that is past due, a promissory note for $250,000 at 15% interest, advances of $35,000, and $415,922 in loans under the terms of revenue factoring agreement with three different lenders at an average rate of 18%

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Preferred stock, par value		$ 0.0001		$ 0.0001
Preferred stock, shares authorized		20,000,000		20,000,000
Preferred stock, shares issued		4,250,579		4,250,579
Preferred stock, shares outstanding		4,250,579		4,250,579
Common stock, par value	$ 0.0001	$ 0.0001		$ 0.0001
Common stock, shares authorized	2,000,000,000	2,000,000,000		2,000,000,000
Common stock, shares issued	1,459,256,460	1,411,799,497		1,211,495,162
Common stock, shares outstanding	1,459,256,460	1,411,799,497		1,211,495,162
Stage It Corp [Member]
Common stock, par value			$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized			20,000,000	20,000,000	20,000,000
Common stock, shares issued			972,614	972,614	972,614
Common stock, shares outstanding			972,614	972,614	972,614
Preferred Stock A [Member] \| Stage It Corp [Member]
Preferred stock, par value			$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized			400,000	400,000	400,000
Preferred stock, shares issued			40,000	40,000	40,000
Preferred stock, shares outstanding			40,000	40,000	40,000
Preferred Stock A 1 [Member] \| Stage It Corp [Member]
Preferred stock, par value			$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized			3,000,000	3,000,000	3,000,000
Preferred stock, shares issued			246,543	246,543	246,543
Preferred stock, shares outstanding			246,543	246,543	246,543
Preferred Stock A 2 [Member] \| Stage It Corp [Member]
Preferred stock, par value			$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized			2,000,000	2,000,000	2,000,000
Preferred stock, shares issued			200,000	200,000	200,000
Preferred stock, shares outstanding			200,000	200,000	200,000
Preferred Stock A 3 [Member] \| Stage It Corp [Member]
Preferred stock, par value			$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized			300,000	300,000	300,000
Preferred stock, shares issued			196,522	196,522	196,522
Preferred stock, shares outstanding			196,522	196,522	196,522

Statements of Operations

Statements of Operations - USD ($)	12 Months Ended
Statements of Operations - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Operating expenses:
General and administrative expenses	$ 601,022
Income(loss) from operations	(587,058)
Other income (expense)
Net loss	(4,553,777)
Stage It Corp [Member]
Revenue-net	890,846	$ (4,809)
Operating expenses:
General and administrative expenses	231,340	51,764
Contractor expenses	455,028	1,805
Payroll expense	1,142,057	41,331
Legal and professional fees	88,411
Total operating expenses	1,916,836	94,900
Income(loss) from operations	(1,025,990)	(99,709)
Other income (expense)
Change in derivative liability	(305,956)	(2,099,025)
Interest expense	(297,562)	(257,289)
Other income (expense), net	(603,518)	(2,356,314)
Net loss	$ (1,629,508)	$ (2,456,023)
Basic and diluted earnings (loss) per common share	$ (1.68)	$ (2.53)
Weighted-average number of common shares outstanding:
Basic and diluted	972,614	972,614

Statements of Changes in Stockh

Statements of Changes in Stockholders' Equity - Stage It Corp [Member] - USD ($)	Preferred Stock Series A [Member]	Preferred Stock Series A One [Member]	Preferred Stock Series A Two [Member]	Preferred Stock Series A Three [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total [Member]
Beginning balance, value at Dec. 31, 2018	$ 4	$ 25	$ 20	$ 20	$ 97	$ 3,963,327	$ (6,483,971)	$ (2,520,478)
Balance, shares at Dec. 31, 2018	40,000	246,543	200,000	196,522	972,614
Net income (loss)							(2,456,023)	(2,456,023)
Ending balance, value at Dec. 31, 2019	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(8,939,994)	(4,976,501)
Balance, shares at Dec. 31, 2019	40,000	246,543	200,000	196,522	972,614
Net income (loss)							(617,171)	(617,171)
Ending balance, value at Sep. 30, 2020	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(9,557,166)	(5,593,672)
Balance, shares at Sep. 30, 2020	40,000	246,543	200,000	196,522	972,614
Beginning balance, value at Dec. 31, 2019	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(8,939,994)	(4,976,501)
Balance, shares at Dec. 31, 2019	40,000	246,543	200,000	196,522	972,614
Net income (loss)							(1,629,508)	(1,629,508)
Ending balance, value at Dec. 31, 2020	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(10,569,502)	(6,606,009)
Balance, shares at Dec. 31, 2020	40,000	246,543	200,000	196,522	972,614
Beginning balance, value at Dec. 31, 2020	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(10,569,502)	(6,606,009)
Balance, shares at Dec. 31, 2020	40,000	246,543	200,000	196,522	972,614
Net income (loss)							(2,813,659)	(2,813,659)
Ending balance, value at Sep. 30, 2021	$ 4	$ 25	$ 20	$ 20	$ 97	4,454,592	(13,383,162)	(8,928,404)
Balance, shares at Sep. 30, 2021	40,000	246,543	200,000	196,522	972,614
Beginning balance, value at Dec. 31, 2020	$ 4	$ 25	$ 20	$ 20	$ 97	$ 3,963,327	$ (10,569,502)	$ (6,606,009)
Balance, shares at Dec. 31, 2020	40,000	246,543	200,000	196,522	972,614

Statements of Cash Flows

Statements of Cash Flows - USD ($)	12 Months Ended
Statements of Cash Flows - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities
Net loss	$ (4,553,777)
Change in balance sheet accounts
Prepaid expenses	(100,000)
Accrued interest	100,500
Net cash provided by (used in) operating activities	(518,493)
Cash flows from investing activities
Net cash used in investing activities	0
Net increase (decrease) in cash and cash equivalents	(47,638)
Cash and cash equivalents at end of period	4,458
Supplemental disclosure of cash flow information:
Cash paid for interest	0
Cash paid for income taxes	0
Stage It Corp [Member]
Cash flows from operating activities
Net loss	(1,629,508)	$ (2,456,023)
Depreciation	4,468
Change in balance sheet accounts
Prepaid expenses	1,288	(1,288)
Other assets	(9,079)	(21,834)
Accounts payable	203,292	13,795
Accrued liabilities	1,085,947	98,529
Accrued interest	297,562	257,289
Derivative liability	305,956	2,099,025
Net cash provided by (used in) operating activities	259,926	(10,506)
Cash flows from investing activities
Purchase of fixed assets	(67,380)
Net cash used in investing activities	(67,380)
Net increase (decrease) in cash and cash equivalents	192,546	(10,506)
Cash and cash equivalents at beginning of period	88,457	98,963
Cash and cash equivalents at end of period	281,003	88,457
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes

Balance Sheet (Unaudited)

Balance Sheet (Unaudited) - USD ($)	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents		$ 4,458
Prepaid expense		100,000
Total current assets		104,458
Total assets		104,458
Current liabilities:
Accrued liabilities		466,801
Accrued interest		2,372,072
Convertible notes		1,956,922
Total current liabilities		8,351,979
Total liabilities		8,351,979
Commitments and contingencies		0
Stockholders’ Equity:
Preferred Stock value		413
Common stock, $0.0001 par value, 20,000,000 shares authorized, 972,614 shares issued and outstanding as of September 30, 2021 and December 31, 2020		121,149
Additional paid in capital		8,386,593
Accumulated deficit		(16,755,676)
Total stockholders’ equity		(8,247,521)
Total liabilities and equity		104,458
Stage It Corp [Member]
Current assets:
Cash and cash equivalents	$ 69,342	281,003	$ 88,457
Prepaid expense	1,854		1,288
Other assets		127,874	118,795
Total current assets	71,196	408,877	208,540
Fixed assets -net	60,303	62,912
Total assets	131,499	471,789	208,540
Current liabilities:
Accounts payable	599,817	427,087	223,795
Accrued liabilities	2,313,671	1,785,861	699,914
Accrued interest	840,197	650,654	502,916
Accrued interest -related party	893,632	767,715	617,891
Notes payable	879,922	179,000
Convertible notes -related party	547,500	547,500	547,500
Convertible notes	315,000	315,000	315,000
Derivative liability	2,670,163	2,404,981
Total current liabilities	9,059,902	7,077,798	5,185,041
Total liabilities	9,059,902	7,077,798	5,185,041
Commitments and contingencies
Stockholders’ Equity:
Common stock, $0.0001 par value, 20,000,000 shares authorized, 972,614 shares issued and outstanding as of September 30, 2021 and December 31, 2020	97	97	97
Additional paid in capital	4,454,592	3,963,327	3,963,327
Accumulated deficit	(13,383,161)	(10,569,502)	(8,939,994)
Total stockholders’ equity	(8,928,404)	(6,606,009)	(4,976,502)
Total liabilities and equity	131,499	471,789	208,540
Stage It Corp [Member] \| Preferred Stock A [Member]
Stockholders’ Equity:
Preferred Stock value	4	4	4
Stage It Corp [Member] \| Preferred Stock A 1 [Member]
Stockholders’ Equity:
Preferred Stock value	25	25	25
Stage It Corp [Member] \| Preferred Stock A 2 [Member]
Stockholders’ Equity:
Preferred Stock value	20	20	20
Stage It Corp [Member] \| Preferred Stock A 3 [Member]
Stockholders’ Equity:
Preferred Stock value	$ 20	$ 20	$ 20

Balance Sheet (Unaudited) (Pare

Balance Sheet (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Preferred stock, par value		$ 0.0001		$ 0.0001
Preferred stock, shares authorized		20,000,000		20,000,000
Preferred stock, shares issued		4,250,579		4,250,579
Preferred stock, shares outstanding		4,250,579		4,250,579
Common stock, par value	$ 0.0001	$ 0.0001		$ 0.0001
Common stock, shares authorized	2,000,000,000	2,000,000,000		2,000,000,000
Common stock, shares issued	1,459,256,460	1,411,799,497		1,211,495,162
Common stock, shares outstanding	1,459,256,460	1,411,799,497		1,211,495,162
Stage It Corp [Member]
Common stock, par value			$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized			20,000,000	20,000,000	20,000,000
Common stock, shares issued			972,614	972,614	972,614
Common stock, shares outstanding			972,614	972,614	972,614
Preferred Stock A [Member] \| Stage It Corp [Member]
Preferred stock, par value			$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized			400,000	400,000	400,000
Preferred stock, shares issued			40,000	40,000	40,000
Preferred stock, shares outstanding			40,000	40,000	40,000
Preferred Stock A 1 [Member] \| Stage It Corp [Member]
Preferred stock, par value			$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized			3,000,000	3,000,000	3,000,000
Preferred stock, shares issued			246,543	246,543	246,543
Preferred stock, shares outstanding			246,543	246,543	246,543
Preferred Stock A 2 [Member] \| Stage It Corp [Member]
Preferred stock, par value			$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized			2,000,000	2,000,000	2,000,000
Preferred stock, shares issued			200,000	200,000	200,000
Preferred stock, shares outstanding			200,000	200,000	200,000
Preferred Stock A 3 [Member] \| Stage It Corp [Member]
Preferred stock, par value			$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized			300,000	300,000	300,000
Preferred stock, shares issued			196,522	196,522	196,522
Preferred stock, shares outstanding			196,522	196,522	196,522

Statements of Operation (Unaudi

Statements of Operation (Unaudited) - USD ($)	9 Months Ended		12 Months Ended
Statements of Operation (Unaudited) - USD ($)	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Operating expenses:
General and administrative expenses			$ 601,022
Income(loss) from operations			(587,058)
Other income (expense)
Net loss			$ (4,553,777)
Weighted-average number of common shares outstanding:
Basic and diluted			1,135,193,463
Stage It Corp [Member]
Revenue-net	$ 313,811	$ 895,145	$ 890,846	$ (4,809)
Operating expenses:
General and administrative expenses	212,728	122,032	231,340	51,764
Contractor expenses	259,686	242,963	455,028	1,805
Payroll expense	1,320,436	658,317	1,142,057	41,331
Stock-based compensation	491,265
Legal and professional fees	114,150	36,365	88,411
Total operating expenses	2,398,265	1,059,677	1,916,836	94,900
Income(loss) from operations	(2,084,454)	(164,532)	(1,025,990)	(99,709)
Other income (expense)
Change in derivative liability	(265,182)	(229,467)	(305,956)	(2,099,025)
Interest expense	(464,023)	(223,172)	(297,562)	(257,289)
Other income (expense), net	(729,205)	(452,639)	(603,518)	(2,356,314)
Net loss	$ (2,813,659)	$ (617,171)	$ (1,629,508)	$ (2,456,023)
Basic and diluted earnings (loss) per common share	$ (2.89)	$ (0.63)	$ (1.68)	$ (2.53)
Weighted-average number of common shares outstanding:
Basic and diluted	972,614	972,614

Statement of Changes in Stockho

Statement of Changes in Stockholders' Equity (Unaudited) - Stage It Corp [Member] - USD ($)	Preferred Stock Series A [Member]	Preferred Stock Series A One [Member]	Preferred Stock Series A Two [Member]	Preferred Stock Series A Three [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total [Member]
Beginning balance, value at Dec. 31, 2018	$ 4	$ 25	$ 20	$ 20	$ 97	$ 3,963,327	$ (6,483,971)	$ (2,520,478)
Balance, shares at Dec. 31, 2018	40,000	246,543	200,000	196,522	972,614
Net income (loss)							(2,456,023)	(2,456,023)
Ending balance, value at Dec. 31, 2019	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(8,939,994)	(4,976,501)
Balance, shares at Dec. 31, 2019	40,000	246,543	200,000	196,522	972,614
Net income (loss)							(617,171)	(617,171)
Ending balance, value at Sep. 30, 2020	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(9,557,166)	(5,593,672)
Balance, shares at Sep. 30, 2020	40,000	246,543	200,000	196,522	972,614
Beginning balance, value at Dec. 31, 2019	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(8,939,994)	(4,976,501)
Balance, shares at Dec. 31, 2019	40,000	246,543	200,000	196,522	972,614
Net income (loss)							(1,629,508)	(1,629,508)
Ending balance, value at Dec. 31, 2020	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(10,569,502)	(6,606,009)
Balance, shares at Dec. 31, 2020	40,000	246,543	200,000	196,522	972,614
Beginning balance, value at Dec. 31, 2020	$ 4	$ 25	$ 20	$ 20	$ 97	3,963,327	(10,569,502)	(6,606,009)
Balance, shares at Dec. 31, 2020	40,000	246,543	200,000	196,522	972,614
Net income (loss)							(2,813,659)	(2,813,659)
Stock based compensation						491,265		491,265
Ending balance, value at Sep. 30, 2021	$ 4	$ 25	$ 20	$ 20	$ 97	4,454,592	(13,383,162)	(8,928,404)
Balance, shares at Sep. 30, 2021	40,000	246,543	200,000	196,522	972,614
Beginning balance, value at Dec. 31, 2020	$ 4	$ 25	$ 20	$ 20	$ 97	$ 3,963,327	$ (10,569,502)	$ (6,606,009)
Balance, shares at Dec. 31, 2020	40,000	246,543	200,000	196,522	972,614

Statement of Cash Flows (Unaudi

Statement of Cash Flows (Unaudited) - USD ($)	9 Months Ended		12 Months Ended
Statement of Cash Flows (Unaudited) - USD ($)	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities
Net loss			$ (4,553,777)
Change in balance sheet accounts
Prepaid expenses			(100,000)
Accrued liabilities			100,500
Net cash provided by (used in) operating activities			(518,493)
Cash flows from investing activities
Net cash used in investing activities			0
Cash flows from financing activities:
Net cash provided by (used in) financing activities			470,855
Net increase (decrease) in cash and cash equivalents			(47,638)
Cash and cash equivalents at beginning of period	$ 4,458
Cash and cash equivalents at end of period			4,458
Supplemental disclosure of cash flow information:
Cash paid for interest			0
Cash paid for income taxes			0
Stage It Corp [Member]
Cash flows from operating activities
Net loss	(2,813,659)	$ (617,171)	(1,629,508)	$ (2,456,023)
Depreciation	17,767		4,468
Stock based compensation	491,265
Change in balance sheet accounts
Prepaid expenses	(1,854)	(2,480)	1,288	(1,288)
Other assets	127,874	(75,038)	(9,079)	(21,834)
Accounts payable	172,729	195,210	203,292	13,795
Accrued liabilities	527,811	729,760	297,562	257,289
Accrued interest	315,460	223,172
Derivative liability	265,182	229,467	305,956	2,099,025
Net cash provided by (used in) operating activities	(897,425)	682,920	259,926	(10,506)
Cash flows from investing activities
Purchase of fixed assets	(15,157)	(21,789)
Net cash used in investing activities	(15,157)	(21,789)	(67,380)
Cash flows from financing activities:
Proceeds from notes payable	700,922
Net cash provided by (used in) financing activities	700,922
Net increase (decrease) in cash and cash equivalents	(211,660)	661,131	192,546	(10,506)
Cash and cash equivalents at beginning of period	281,003	88,457	88,457	98,963
Cash and cash equivalents at end of period	69,342	749,588	281,003	88,457
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash	$ 60,458	$ 36,958
Prepaid expenses	100,000	464,336
Total current assets	160,458	501,294
Fixed assets, net	35,002	0
Goodwill	10,400,000
Intangible Assets	2,491,667
Total assets	13,087,127	501,294
Current liabilities:
Accounts payable and accrued expenses	2,702,949	923,781
Shares to be issued	1,192,290	247,707
Accrued payroll-officers	231,750	233,750
Advances from officer	10,000	10,000
Notes payable	1,142,542	869,157
Deferred revenue	857,326	74,225
Convertible notes payable, net	638,714	635,714
Purchase liability	7,979,984	300,000
Total current liabilities	14,755,555	3,294,334
Total liabilities	14,755,555	3,294,334
Commitments and Contingencies	0	0
Stockholders’ Deficit
Preferred stock, value		425
Common stock, par value $0.0001, 2,000,000,000 shares authorized; 1,411,799,497 and 1,211,495,162 shares issued and outstanding, as of December 31, 2021, and December 31, 2020, respectively	145,925	141,177
Additional paid-in capital	13,213,622	10,900,652
Accumulated deficit	(15,028,400)	(13,835,294)
Total stockholders’ deficit	(1,668,428)	(2,793,040)
Total Liabilities and Stockholders’ Deficit	13,087,127	501,294
Series A Preferred Stock [Member]
Stockholders’ Deficit
Preferred stock, value	425	425
Series B Preferred Stock [Member]
Stockholders’ Deficit
Preferred stock, value

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Preferred Stock, Par or Stated Value Per Share		$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized		20,000,000	20,000,000
Preferred Stock, Shares Issued		4,250,579	4,250,579
Preferred Stock, Shares Outstanding		4,250,579	4,250,579
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	2,000,000,000	2,000,000,000	2,000,000,000
Common Stock, Shares, Issued	1,459,256,460	1,411,799,497	1,211,495,162
Common Stock, Shares, Outstanding	1,459,256,460	1,411,799,497	1,211,495,162
Series A Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	20,000,000	20,000,000
Preferred Stock, Shares Issued	4,250,579	4,250,579
Preferred Stock, Shares Outstanding	4,250,579	4,250,579
Series B Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	1,600	1,600
Preferred Stock, Shares Issued	1,535		0
Preferred Stock, Shares Outstanding	1,535	0

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Revenues - related party	$ 5,049	$ 2,261
Revenue, net	36,621
Total revenue	41,670	2,261
Direct costs of revenue	40,513
Gross margin (loss)	1,157	2,261
Operating expenses:
General and administrative expense	63,202	17,073
Payroll expenses	121,551	65,750
Professional fees	351,953	91,205
Amortization of intangible assets	108,333
Total costs and expenses	645,039	174,028
Operating loss	(643,882)	(171,767)
Other income (expense), net
Change in fair value of derivative liability		2,344,234
Financing costs	(549,224)	(181,366)
Other income (expense), net	(549,224)	2,162,868
Net income (loss)	$ (1,193,106)	$ 1,991,101
Net loss per common share - basic and diluted	$ 0	$ 0
Weighted average common shares outstanding:
Basic and diluted	1,415,312,830	1,211,495,162

(UNAUDITED) CONDENSED CONSOLIDA

(UNAUDITED) CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Preferred A Shares [Member]	Preferred B Shares [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Ending Balance, shares at Dec. 31, 2019			770,883,602
Beginning Balance, shares at Dec. 31, 2019			770,883,602
Shares issued for services			$ 50	$ 100		$ 100
Shares issued for services, Shares			500,000
Net loss					$ (4,553,777)	(4,553,777)
Ending balance, value at Dec. 31, 2020	$ 413		$ 121,149	8,386,593	(16,755,676)	(8,247,521)
Ending Balance, shares at Dec. 31, 2020	4,126,776		1,211,495,162
Beneficial conversion feature of convertible notes				111,765		111,765
Net loss					1,991,101	1,991,101
Ending balance, value at Mar. 31, 2021	$ 413		$ 121,149	8,498,358	(14,764,575)	(6,144,655)
Ending Balance, shares at Mar. 31, 2021	4,126,776		1,211,495,162
Beginning balance, value at Dec. 31, 2020	$ 413		$ 121,149	8,386,593	(16,755,676)	(8,247,521)
Beginning Balance, shares at Dec. 31, 2020	4,126,776		1,211,495,162
Beginning balance, value at Dec. 31, 2020	$ 413		$ 121,149	8,386,593	(16,755,676)	(8,247,521)
Beginning Balance, shares at Dec. 31, 2020	4,126,776		1,211,495,162
Beneficial conversion feature of convertible notes				111,765		111,765
Net loss					2,920,382	2,920,382
Ending balance, value at Dec. 31, 2021	$ 425		$ 141,177	10,900,652	(13,835,294)	(2,793,040)
Ending Balance, shares at Dec. 31, 2021	4,250,579		1,411,779,497
Issuance of Preferred B Shares				1,500,000		1,500,000
Issuance of Preferred B Shares, Shares		1,500
Financing fee paid in Preferred B shares				42,000		42,000
Financing fee paid in Preferred B shares, Shares		35
Benefical conversion feature of Preferred B Stock				300,000		300,000
Shares issued for services			$ 600	56,200		56,800
Shares issued for services, Shares			6,000,000
Acquisition shares issued for Stage It purchase			$ 4,148	414,770		418,917
Acquisition shares issued for Stage It purchase, Shares			41,476,963
Net loss					(1,193,106)	(1,193,106)
Ending balance, value at Mar. 31, 2022	$ 425		$ 145,925	$ 13,213,621	$ (15,028,400)	$ (1,668,428)
Ending Balance, shares at Mar. 31, 2022	4,250,579	1,535	1,459,256,460

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash Flows From Operating Activities:
Net income (loss)	$ (1,193,106)	$ 1,991,101
Adjustments to reconcile net income to net cash provided by (used for) operating activities
Depreciation	1,880	0
Amortization of intangible assets	108,333
Change in the fair value of derivatives		(2,344,233)
Beneficial conversion feature of Preferred B stock	300,000
Shares issued for financing costs	42,000
Shares issued for services	56,800
Amortization of debt discount		111,765
Changes in operating assets and liabilities
Prepaid expenses	364,336
Accounts payable and accrued interest	67,817	60,348
Deferred revenue	5,198
Accrued payroll officers	(2,000)	7,000
Net cash used in operating activities	(248,739)	(174,019)
Cash Flows From Investing Activities:
Acquisition of a business net of cash received	(977,761)
Net cash used in investing activities	(977,761)
Cash Flows From Financing Activities:
Payments on promissory note	(253,000)
Proceeds from the of Series B Preferred Stck	1,500,000
Proceeds from the issuance of convertible notes	3,000	227,000
Net cash provided by investing activities	1,250,000	227,000
Net Decrease In Cash	23,500	52,981
Cash At The Beginning Of The Period	36,958	4,458
Cash At The End Of The Period	60,458	57,439
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes
Supplemental disclosure of non-cash information:
Common shares issued upon conversion of notes payable and accrued interest

ORGANIZATION AND BASIS OF PRESE

ORGANIZATION AND BASIS OF PRESENTATION	3 Months Ended	9 Months Ended	12 Months Ended
ORGANIZATION AND BASIS OF PRESENTATION	Mar. 31, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
ORGANIZATION AND BASIS OF PRESENTATION	NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION History and Organization VNUE, Inc. (formerly Tierra Grande Resources, Inc.) (“VNUE”, “TGRI”, or the “Company”) was incorporated under the laws of the State of Nevada on April 4, 2006. On May 29, 2015, VNUE, Inc. entered into a merger agreement with VNUE Washington, Inc. Pursuant to the terms of the Merger Agreement, all of the outstanding shares of any class or series of VNUE Washington were exchanged for an aggregate of 50,762,987 shares of TGRI common stock. As a result of the Merger, VNUE Washington became a wholly-owned subsidiary of the Company, and the transaction was accounted for as a reverse merger with VNUE Washington deemed the acquiring company for accounting purposes, and the Company deemed the legal acquirer. The Company is developing technology-driven solutions for Artists, Venues, and Festivals to automate the capturing, publishing, and monetization of their content, as well as protection of their rights. On February 13, 2022, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with VNUE Acquisition Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“MergerCo”), Stage It Corp., a Delaware corporation (“Stage It”), and the stockholders’ representative for Stage It, pursuant to which the Company will acquire Stage It for up to $10 million (the “Merger Consideration”), by merging MergerCo with and into Stage It, with Stage It continuing as the surviving entity and wholly-owned subsidiary of the Company (the “Merger”). Pursuant to the Merger Agreement, and subject to the terms and conditions set forth therein, at the closing of the Merger (the “Closing”), each of Stage It’s outstanding shares (including common and preferred shares) will be converted into the right to receive the applicable portion of the Merger Consideration. A portion of the Merger Consideration will be paid in cash and take the form of satisfying certain outstanding debt obligations of Stage It, as outlined in a Closing Payment Certificate of the Merger Agreement, and the other portion will be paid in shares of the Company’s common stock or preferred stock, with the actual number of such shares to be issued reduced by the cash component outlaid in the transaction. A portion of the Merger Consideration, $1 million, will be held back for the purposes of satisfying certain contingent obligations of Stage It. The Merger Agreement also allows for the issuance of earn-out shares, not to exceed the overall Merger Consideration, provided that certain EBIDTA requirements are met over the course of 18 months. See Note 5. for additional information		NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION History and Organization VNUE, Inc. (formerly Tierra Grande Resources, Inc.) (“VNUE”, “TGRI”, or the “Company”) was incorporated under the laws of the State of Nevada on April 4, 2006. On May 29, 2015, VNUE, Inc. entered into a merger agreement with VNUE Washington, Inc. Pursuant to the terms of the Merger Agreement, all of the outstanding shares of any class or series of VNUE Washington were exchanged for an aggregate of 50,762,987 The Company is developing technology driven solutions for Artists, Venues and Festivals to automate the capturing, publishing, and monetization of their content, as well as protection of their rights. Going Concern The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, during the year ended December 31, 2021 the Company used cash in operations of $ 1,430,312 13,835,294 2,793,040 On December 31, 2021, the Company had cash on hand of $ 36,958
Stage It Corp [Member]
ORGANIZATION AND BASIS OF PRESENTATION		NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION History and Organization Stage It Corp. (“Stage It”, or the “Company”) is a Delaware corporation formed in that operates an online venue for live an interactive performances through its technology platform that enables content creators to perform and create ticketed events, and provides fans with an opportunity to watch live shows, and ask artists questions and request songs. Going Concern The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, during the nine months ended September 30, 2021 the Company incurred a net loss of $ 2,813,659 8,988,706 On As of September 30, 2021, the Company had cash on hand of $ 69,342		NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION History and Organization Stage It Corp. (“Stage It”, or the “Company”) is a Delaware corporation formed in that operates an online venue for live an interactive performances through its technology platform that enables content creators to perform and create ticketed events, and provides fans with an opportunity to watch live shows, and ask artists questions and request songs. Going Concern The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, during the year ended December 31, 2020 the Company incurred a net loss of $ 1,629,508 6,668,922 On December 31, 2020, the Company had cash on hand of $ 281,033

SIGNIFICANT AND CRITICAL ACCOUN

SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES	3 Months Ended	9 Months Ended	12 Months Ended
SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES	Mar. 31, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES	NOTE 3 – SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES Basis of Consolidation The accompanying financial statements have been prepared in accordance with the Financial Accounting Standards Board (“ FASB Codification GAAP The Company consolidates its results with its wholly-owned subsidiary, Stage It Corp. Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts Stage It receives revenue through a percentage of ticket sales and tipping. This show-based revenue creates a pool that is shared with the performing artist. Once a show is completed the revenue that has been created through tickets and tips is allocated. Typically, Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer, however, there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as an agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production. The Company also recognizes revenue on the sale of CDs and USB drives that contain the recording of live concerts and are made available to concert attendees immediately after the show and online. Revenue is recognized on the sale of a product when our performance obligation is completed which is when the risk of loss transfers to our customers and the collection of the receivable is reasonably assured, which generally occurs when the product is purchased. As of March 31, 2022 and December 31, 2021 deferred revenue amounted to $ 857,326 and $ 74,225 , respectively. Management’s Representation of Interim Financial Statements The accompanying unaudited financial statements have been prepared by the Company without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and disclosures normally included in financial statements prepared in accordance with GAAP have been or omitted as allowed by such rules and regulations, and management believes that the disclosures are adequate to make the information presented not misleading. These financial statements include all of the adjustments, which in the opinion of management are necessary to a fair presentation of financial position and results of operations. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results for a full year. Use of Estimates The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the assumptions used for the determination of goodwill and intangible assets, the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates. Stock Purchase Warrants The Company accounts for warrants issued to purchase shares of its common stock as equity in accordance with FASB ASC 480, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock, Distinguishing Liabilities from Equity. Fair Value of Financial Instruments The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. Income (Loss) per Common Share Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that is then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on March 31, 2022, because their impact was anti-dilutive. As of March 31, 2022, the Company had 149,489,159 outstanding warrants and 20,333,526 shares related to convertible notes payables respectively, which were excluded from the computation of net loss per share. Property and Equipment Property and equipment are stated at cost or fair value if acquired as part of a business combination. Depreciation is computed by the straight-line method and is charged to operations over the estimated useful lives of the assets. The threshold for depreciating office equipment is $ 200 , and $ 1,000 for furniture and fixtures Maintenance and repairs are charged to expense as incurred. The carrying amount and accumulated depreciation of assets sold or retired are removed from the accounts in the year of disposal and any resulting gain or loss is included in the results of operations. The estimated useful lives of property and equipment are as follows: Schedule of estimated useful lives of property and equipment Computers, software, and office equipment 3 years Furniture and fixtures 7 years As of March 31, 2022, the Company’s property, which consisted solely of computers, amounted to $ 35,002 and - 0 -, respectively. Depreciation expense for the three months ended March 31, 2022, and 2021, amounted to $ 1,880 and $- 0 -, respectively. Goodwill and Intangible Assets Goodwill represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized. The goodwill arising from the Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets consist primarily of customer relationships, trademarks, and product formulations. The useful life of these customer relationships is estimated to be three years. Goodwill is not amortized but is subject to annual impairment testing unless circumstances dictate more frequent assessments. The Company performs an annual impairment assessment for goodwill during the fourth quarter of each year and more frequently whenever events or changes in circumstances indicate that the fair value of the asset may be less than the carrying amount. Goodwill impairment testing compares the fair value of the reporting unit to its carrying amount. The fair value of the reporting unit is determined by considering both the income approach and market approaches. The fair values calculated under the income approach and market approaches are weighted based on circumstances surrounding the reporting unit. Under the income approach, the Company determines fair value based on estimated future cash flows of the reporting unit, which are discounted to the present value using discount factors that consider the timing and risk of cash flows. For the discount rate, the Company relies on the capital asset pricing model approach, which includes an assessment of the risk-free interest rate, the rate of return from publicly traded stocks, the Company’s risk relative to the overall market, the Company’s size and industry and other Company-specific risks. Other significant assumptions used in the income approach include the terminal value, growth rates, future capital expenditures, and changes in future working capital requirements. The market approaches use key multiples from guideline businesses that are comparable and are traded on a public market. If the fair value of the reporting unit is greater than its carrying amount, there is no impairment. If the reporting unit’s carrying amount exceeds its fair value, then an impairment loss is recognized in an amount equal to the excess. Recently Issued Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position or results of operations.		NOTE 2 – SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES Basis of Consolidation The Company consolidates all wholly-owned and majority-owned subsidiaries in which the Company’s power to control exists. The Company consolidates the following subsidiaries and/or entities: Schedule of subsidiaries and/or entities Name of consolidated subsidiary or Entity State or other jurisdiction of incorporation or organization Date of incorporation or formation (date of acquisition/ disposition, if applicable) Attributable interest VNUE Inc. (formerly TGRI) The State of Nevada April 4, 2006 100 % VNUE Inc. (VNUE Washington) The State of Washington October 16, 2014 100 % VNUE LLC The State of Washington August 1, 2013 100 % Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts The Company recognizes revenue on the sale CDs and USB drives that contain the recording of live concerts and made available to concert attendees immediately after the show and on-line. Revenue is recognized on the sale of a product when our performance obligation is completed which is when the risk of loss transfers to our customers and the collection of the receivable is reasonably assured, which generally occurs when the product is purchased. Use of Estimates The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the assumptions used for impairment testing of intangible assets, assumptions used to value the derivative liabilities, the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates. Fair Value of Financial Instruments The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates. The fair value of the derivative liabilities of $- 0 3,156,582 Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. Income (Loss) per Common Share Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options. No 15,800,319 11,313,852 Intangible Assets The Company accounts for intangible assets in accordance with the authoritative guidance issued by the FASB. Intangibles are valued at their fair market value and are amortized taking into account the character of the acquired intangible asset and the expected period of benefit. The Company evaluates intangible assets for impairment, at a minimum, on an annual basis and whenever events or changes in circumstances indicate that the carrying value may not be recoverable from its estimated undiscounted future cash flows. Recoverability of intangible assets is measured by comparing their net book value to the related projected undiscounted cash flows from these assets, considering a number of factors, including past operating results, budgets, economic projections, market trends, and product development cycles. If the net book value of the asset exceeds the related undiscounted cash flows, the asset is considered impaired, and a second test is performed to measure the amount of impairment loss. As of December 31, 2020 based on the assessment of Management, the Company determined that its intangible asset had been impaired. Segments The Company operates in one segment for the manufacture and distribution of our products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in economic characteristics; nature of products and services; and procurement, manufacturing, and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements. Recently Issued Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position or results of operations. The Company adopted ASC 842 on January 1, 2019. However, the adoption of the standard had no impact on the Company’s financial statements since all Company leases are month to month, or short-term rentals.
Stage It Corp [Member]
SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES		NOTE 2 – SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES Basis of Presentation The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and are expressed in United States dollars. For the periods ended September 30, 2021 and December 31, 2020 the financial statements include the accounts of the Company, Stage It. Corporation. Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts Stage It receives revenue through a percentage of ticket sales and tipping. This show-based revenue creates a pool that is shared with the performing artist. Once a show is completed the revenue that has been created through tickets and tips is allocated. Typically, Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer, however there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production. Use of Estimates The preparation of the financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the assumptions used to value the derivative liabilities, the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates. Management’s Representation of Interim Financial Statements The accompanying unaudited financial statements have been prepared by the Company without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Company uses the same accounting policies in preparing quarterly and annual financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted as allowed by such rules and regulations, and management believes that the disclosures are adequate to make the information presented not misleading. These financial statements include all of the adjustments, which in the opinion of management are necessary to a fair presentation of financial position and results of operations. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results for a full year. These financial statements should be read in conjunction with the audited financial statements and notes thereto at December 31, 2020. Fair Value of Financial Instruments The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates. The fair value of the derivative liabilities of $ 2,670,163 2,404,091 Property and Equipment Property and equipment are stated at cost or fair value if acquired as part of a business combination. Depreciation is computed by the straight-line method and is charged to operations over the estimated useful lives of the assets. The threshold for depreciating office equipment is $ 200 1,000 Schedule of estimated useful lives Computers, software, and office equipment 3 Furniture and fixtures 7 As of September 30, 2021 and December 31, 2020 the Company’s property which consisted solely of computers amounted to $ 60,303 62,912 17,767 Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. Income (Loss) per Common Share Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options and, preferred stock and convertible notes. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on September 30, 2021 and December 31, 2020 respectively, because their impact was anti-dilutive. Recently Issued Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position or results of operations.		NOTE 2 – SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES Basis of Presentation The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and are expressed in United States dollars. For the years ended December 31, 2020 and 2019, the financial statements include the accounts of the Company, Stage It. Corporation Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts Stage It receives revenue through a percentage of ticket sales and tipping. This show-based revenue creates a pool that is shared with the performing artist. Once a show is completed the revenue that has been created through tickets and tips is allocated. Typically, Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer, however there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production. Use of Estimates The preparation of the financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the assumptions used to value the derivative liabilities, the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates. Fair Value of Financial Instruments The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates. The fair value of the derivative liabilities of $ 2,404,981 2,099,025 Property and Equipment Property and equipment are stated at cost or fair value if acquired as part of a business combination. Depreciation is computed by the straight-line method and is charged to operations over the estimated useful lives of the assets. The threshold for depreciating office equipment is $ 200 1,000 Schedule of estimated useful lives Computers, software, and office equipment 3 Furniture and fixtures 7 As of December 31, 2020 and 2019, the Company’s property, which consisted solely of computers, amounted to $ 62,912 0 4,468 0 Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. Income (Loss) per Common Share Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, which could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options and, preferred stock and convertible notes. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on December 31, 2020 and 2019, respectively, because their impact was anti-dilutive. Recently Issued Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position or results of operations.

PREPAID EXPENSE

PREPAID EXPENSE	3 Months Ended	12 Months Ended
PREPAID EXPENSE	Mar. 31, 2022	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
PREPAID EXPENSE	NOTE 4 – PREPAID EXPENSE As of March 31, 2022 and December 31, 2021, the balances in prepaid expenses was $ 100,000 and $ 464,336 . $ 100,000 of the prepaid expense in both periods relates to a January 9, 2020 agreement entered into by the Company with recording and performance artist, Matchbox Twenty “MT Agreement”), to record its 2020 tour and sell limited edition double CD sets, download cards, and digital downloads. As part of the deal, the Company agreed to pay an advance of $100,000 against sales, to MT and its affiliated companies, which was paid in full in installments, with the last installment of $40,000 paid on March 4, 2020. This tour which has been delayed due to Covid-19 is expected to commence in summer of 2022.	NOTE 3 – PREPAID EXPENSE As of December 31, 2021 and December 31, 2020, the balances in prepaid expenses was $ 464,336 100,000 $100,000 of the prepaid expense in both periods relates to a Jan 9th, 2020 an agreement entered into by the Company with recording and performance artist, Matchbox Twenty “MT Agreement”), to record its 2020 tour and sell limited edition double CD sets, download cards, and digital downloads. As part of the deal, the Company agreed to pay an advance of $100,000 against sales, to MT and its affiliated companies, which was paid in full in installments, with the last installment of $40,000 paid on March 4th. Additionally, during the last half of 2021, the Company advanced $ 364,336

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended	9 Months Ended	12 Months Ended
RELATED PARTY TRANSACTIONS	Mar. 31, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
RELATED PARTY TRANSACTIONS	NOTE 5 – RELATED PARTY TRANSACTIONS DiscLive Network On July 10, 2017, the Company entered into a Licensing Agreement with RockHouse Live Media Productions, Inc., DBA “DiscLive” or “DiscLive Network” (“DiscLive”) to formalize the terms of the Strategic Alliance entered into by the Company with DiscLive on July 21, 2016. VNUE has acquired an exclusive license from DiscLive, for a period of three years unless earlier terminated under the Agreement, for the use of all its assets, including but not limited to the DiscLive brand, website (including eCommerce platform), intellectual property, inventory, equipment, trade secrets and anything related to its business of “instant live” recording. Under the terms of the Agreement, DiscLive granted the Company a worldwide exclusive license. In exchange for the license, DiscLive will receive a license fee equal to five percent (5%) of any sales derived from the sale and use of the products and services. DiscLive is controlled by our Chief Executive Officer. Revenues of $ 5,049 and $ 2,261 for the periods ended March 31, 2022, and 2021, respectively, were recorded using the assets licensed under this agreement. For the periods ended March 31, 2022, and 2021 the fees would have amounted to $ 252 and $ 113 respectively. The Company’s Chief Executive Officer agreed to waive the right to receive these license fees for both years and has never taken any fees pursuant to this agreement. Accrued Payroll to Officers Accrued payroll to two officers was $ 231,750 and $ 233,750 respectively, as of March 31, 2022, and December 31, 2021, respectively. The Chief Executive Officer’s compensation is $ 170,000 per year. Advances from Officers/Stockholders From time to time, officers/stockholders of the Company advance funds to the Company for working capital purposes. During the year ended December 31, 2021, the Company’s CEO advanced $ 10,000 to the Company on an interest-free basis. That amount remained outstanding as of March 31, 2022.		NOTE 4 – RELATED PARTY TRANSACTIONS DiscLive Network On July 10, 2017, the Company entered into a Licensing Agreement with RockHouse Live Media Productions, Inc., DBA “DiscLive” or “DiscLive Network” (“DiscLive”) to formalize the terms of the Strategic Alliance entered into by the Company with DiscLive on July 21, 2016. VNUE has acquired an exclusive license from DiscLive, for a period of three years unless earlier terminated under the Agreement, for the use of all its assets, including but not limited to the DiscLive brand, website (including eCommerce platform), intellectual property, inventory, equipment, trade secrets and anything related to its business of “instant live” recording. Under the terms of the Agreement, DiscLive granted the Company a worldwide exclusive license. In exchange for the license, DiscLive will receive a license fee equal to five percent (5%) of any sales derived from the sale and use of the products and services. DiscLive is controlled by our Chief Executive Officer. Revenues of $ 100,476 22,474 5,024 1,124 Accrued Payroll to Officers Accrued payroll to two officers was $ 233,750 209,750 170,000 Advances from Officers/Stockholders From time to time, officers/stockholders of the Company advance funds to the Company for working capital purposes. During the year ended December 31, 2019, a former employee and stockholder agreed to forgive $ 14,000 14,000
Stage It Corp [Member]
RELATED PARTY TRANSACTIONS		NOTE 3 – RELATED PARTY TRANSACTIONS The Company entered into several convertible promissory notes in 2013, 2014 and 2015 with Evan Lowenstein the company founder and Director, Jaron Lowenstein the brother of Evan, Chuck Lowenstein the father of Evan. The Company also entered into several convertible promissory notes with Robert Jennings over the same period who is a Stage It Director. These notes were issued to fund the early growth of the Company. The notes were issued at 18 547,500 547,500 893,632 767,515		NOTE 3 – RELATED PARTY TRANSACTIONS The Company entered into several convertible promissory notes in 2013, 2014 and 2015 with Evan Lowenstein the company founder and Director, Jaron Lowenstein the brother of Evan, Chuck Lowenstein the father of Evan. The company also entered into several convertible promissory notes with Robert Jennings over the same period who is a Stage It Director. These notes were issued to fund the early growth of the Company. The notes were issued at 18 547,500 547,500 767,715 617,891

ACCOUNTS PAYABLE AND ACCRUED LI

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	3 Months Ended	9 Months Ended	12 Months Ended
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	Mar. 31, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	NOTE 8 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts payables are recognized initially at the transaction price and subsequently measured at the undiscounted amount of cash or other consideration expected to be paid. Accrued expenses are recognized based on the expected amount required to settle the obligation or liability. The following table sets forth the components of the Company’s accrued liabilities on March 31, 2022, and December 31, 2021: Schedule of accrued liabilities March 31, 2022 December 31, 2021 Accounts payable and accrued expense 2,298,240 $ 588,275 Accrued interest 259,179 189,527 Soundstr Obligation 145,529 145,259 Total accounts payable and accrued liabilities 2,702,948 $ 923,061		NOTE 5 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts payables are recognized initially at the transaction price and subsequently measured at the undiscounted amount of cash or other consideration expected to be paid. Accrued expenses are recognized based on the expected amount required to settle the obligation or liability. The following table sets forth the components of the Company’s accrued liabilities on December 31, 2021, and December 31, 2020: Schedule of accrued liabilities December 31, 2021 December 31, 2020 Accounts payable and accrued expense (includes $93,625 due to a former officer) $ 588,275 $ 587,230 Accrued interest 189,527 466,801 Accrued interest and penalties Golock - 1,172,782 Soundstr Obligation 145,259 145,259 Total accounts payable and accrued liabilities 923,061 $ 2,372,072
Stage It Corp [Member]
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES		NOTE 4 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts payables are recognized initially at the transaction price and subsequently measured at the undiscounted amount of cash or other consideration expected to be paid. Accrued expenses are recognized based on the expected amount required to settle the obligation or liability. The following table sets forth the components of the Company’s accrued liabilities on September 30, 2021, and December 31, 2020. Schedule of accounts payable and accrued liabilities September 30, 2021 December 31, 2020 Accounts payable $ 599,817 $ 427,086 Accrued liabilities (a)(b) 2,313,671 1,785,861 Accrued interest 840,197 650,654 Accrued interest- related parties 893,632 767,715 Total accounts payable and accrued liabilities $ 4,647,317 $ 2,404,981 (a) Includes $887,120 in liabilities due to artists, $846,477 in unredeemed outstanding notes purchased by users, and $376,703 in payroll liabilities as of September 30, 2021 (b) Includes $946,537 in liabilities due to artists and $781,172 in unredeemed outstanding notes purchased by users as of December 31, 2020		NOTE 4 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts payables are recognized initially at the transaction price and subsequently measured at the undiscounted amount of cash or other consideration expected to be paid. Accrued expenses are recognized based on the expected amount required to settle the obligation or liability. The following table sets forth the components of the Company’s accrued liabilities on December 31, 2020, and December 31, 2019. Schedule of accounts payable and accrued liabilities December 31, December 31, Accounts payable $ 427,086 $ 223,795 Accrued liabilities (a)(b) 1,785,861 699,914 Accrued interest 650,654 502,916 Accrued interest- related parties 767,715 617,891 Total accounts payable and accrued liabilities $ 2,404,981 $ 2,044,516 (a) Includes $946,537 in liabilities due to artists and $791,172 in unredeemed outstanding notes purchased by users as of December 31, 2020 (b) Includes $398,729 in liabilities due to artists and $297,795 in unredeemed outstanding notes purchased by users as of December 31, 2019

PURCHASE LIABILITY

PURCHASE LIABILITY	3 Months Ended	12 Months Ended
PURCHASE LIABILITY	Mar. 31, 2022	Dec. 31, 2021
Purchase Liability
PURCHASE LIABILITY	NOTE 9 – PURCHASE LIABILITY The balance of the company’s Purchase Liability at March 31, 2022, and December 31, 2021 was $ 7,979,984 and $ 300,000 , respectively. Under the terms of the business acquisition of Stage It described in Note 6, during the three months ended March 31, 2022 the Company had a contingent Earnout Liability of $ 7,679,984 due to the shareholders of Stage It if Stage It operations achieve certain operating milestones. This liability will be subject to quarterly analysis. On October 16, 2017, the Company entered into an agreement with PledgeMusic, Inc. (the “Seller”), whereby the Company acquired the digital live music distribution platform “Set.fm” from PledgeMusic. The purchase price for the acquisition was comprised of $ 50,000 paid in cash, and a purchase liability of $ 300,000 . The purchase liability was payable on the net revenues derived from VNUE’s live recording and content business and must be paid in full to the Seller no later than the three (3) year anniversary of the date of the agreement, or October 16, 2020. If the Company fails to pay the Seller the purchase liability on time, the Seller may request at any time within one hundred eighty days (180) days following the (3) year anniversary of the asset purchase agreement, that the Company immediately forfeit, convey, assign, and transfer to the Seller all or any of the Purchased Assets so requested by the Seller for no additional consideration. The Company has had no correspondence regarding this liability with Pledge Music who declared bankruptcy in 2019.	NOTE 6 – PURCHASE LIABILITY On October 16, 2017, the Company entered into an agreement with PledgeMusic, Inc. (the “Seller”), whereby the Company acquired the digital live music distribution platform “Set.fm” from PledgeMusic. The purchase price for the acquisition was comprised of $ 50,000 300,000 350,000 350,000 116,668 204,165 The Company has had no correspondence regarding this liability with Pledge Music who declared bankruptcy in 2019.

SHARES TO BE ISSUED

SHARES TO BE ISSUED	3 Months Ended	12 Months Ended
SHARES TO BE ISSUED	Mar. 31, 2022	Dec. 31, 2021
Shares To Be Issued
SHARES TO BE ISSUED	NOTE 10 – SHARES TO BE ISSUED As of December 31, 2021 the Company had not yet issued 5,204,352 shares of common stock with a value of $ 247,707 for past services provided and for an acquisition. During the three months ended March 31, 2022, pursuant to the acquisition of Stage It described throughout this Report, an additional 93,523,037 shares issuable to Stage It shareholders valued at $ 944,583 were added to the previous balance of shares to be issued.	NOTE 7 – SHARES TO BE ISSUED As of December 31, 2018, the Company had not yet issued 3,964,352 243,839 240,000 184 1,000,000 3,500 5,204,352 247,707

NOTES PAYABLE

NOTES PAYABLE	3 Months Ended	9 Months Ended	12 Months Ended
NOTES PAYABLE	Mar. 31, 2022	Sep. 30, 2021	Dec. 31, 2021
NOTES PAYABLE	NOTE 11 – NOTES PAYABLE The balance of the Notes Payable outstanding as of March 31, 2022, and December 31, 2021, was $ 1,142,542 and $ 869,157 , respectively. The balances as of December 31, 2021 were comprised of two notes amounting to $ 12,000 and an 8 % note for $ 857,157 due to Ylimit payable on September 30, 2022. The two notes for $12,000 are past due an continue to accrue interest. During the three months ended March 31, 2022, the Company added $ 273,385 in note liabilities pursuant to the Stage It acquisition. These notes currently are not accruing interest.		NOTE 8 – NOTES PAYABLE The balance of the Notes Payable outstanding was $ 869,157 34,000 12,000 8 857,157 12,000
Stage It Corp [Member]
NOTES PAYABLE		NOTE 5 – NOTES PAYABLE The following table sets forth the components of the Company’s notes payable on September 30, 2021, and December 31, 2020. Schedule of notes payable September 30, December 31, Notes payable (a) $ 879,722 $ 179,000 Convertible notes related party-past due (b) 547,500 547,500 Convertible notes-past due (b) 315,000 315,000 Total notes payable $ 1,742,422 $ 1,041,500 (a) Notes payable are comprised of a note for $179,000 at 15% interest in both period that is past due, a promissory note for $250,000 at 15% interest, advances of $35,000, and $415,922 in loans under the terms of revenue factoring agreement with three different lenders at an average rate of 18% (b) The Company entered into several convertible promissory notes in 2013, 2014 and 2015 with several related parties (see Note 3) and third parties. These notes were issued to fund the early growth of the Company. The notes were issued at 18% interest compound annually and can only convert to common stock upon the occurrence of a qualified funding, which has not occurred

CONVERTIBLE NOTES PAYABLE AND N

CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE, RELATED PARTIES	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Debt Disclosure [Abstract]
CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE, RELATED PARTIES	NOTE 12 – CONVERTIBLE NOTES PAYABLE Convertible notes payable consist of the following: Schedule of Convertible notes payable March 31, December 31, Various Convertible Notes $ 43,500 43,500 Golock Capital, LLC Convertible Notes (a) 339,011 339,011 Other Convertible Notes (b) 256,203 253,203 Total Convertible Notes $ 638,714 635,714 (a) On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Lender”) in the principal amount of $ 40,000 with an interest rate at 10 % per annum and a maturity date of November 2, 2018 . The note included an original issue discount of $5,000. The note is convertible into shares of the Company’s common stock at $ 0.015 per share. As additional consideration for the Lender to enter into this agreement with the Company, the Company issued warrants to the Lender to acquire in the aggregate 2,500,000 shares of the Company’s common stock at an exercise price of $0.015 per share that expire three years from the date of grant. The relative fair value of the warrants, the original issue discount, and the beneficial conversion feature totaling $ 40,000 was recorded as a debt discount and will be amortized to interest expense over the term of the note. On November 5, 2018, the Company amended the notes above by changing the conversion feature for the aggregate notes to be convertible into shares of common stock of the Company at the lower of (i) $0.015 per share or, (ii) 58% of the lowest closing bid price in the 20 trading days prior to the day that the Lender requests conversion. This feature gave rise to a derivative liability of $ 553,000 at the date of issuance as discussed below. The amendment also increased the principal face amount of notes to include accrued interest, and an additional $ 43,250 was added to principal, which was recorded to financing costs. The aggregate balance of the notes outstanding, and the related debt discount was $ 302,067 and $ 0 , respectively, as of December 31, 2018. On April 29, 2019, Golock entered into an amendment with the Company to extend the maturity of the Notes until July 31, 2019. In return, Golock received several concessions. They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender requested conversion. During the year ending December 31, 2019, the Company issued new notes payable of $ 53,331 and $ 23,102 of notes and accrued interest were converted into 100,000,000 shares of common stock. The balance of the notes outstanding on December 31, 2019, was $ 339,010 . As of December 31, 2019, $ 285,679 of these notes were past due. As of March 31, 2022 all of the Golock notes amounting to $ 339,011 were past due. As a result Golock has assessed the Company additional penalties and interest of $ 1,172,782 . The Company disagrees with the accrued interest and penalties due to Golock. Initially, the Company recorded this amount as a liability on its balance during the period ended March 31, 2021. Subsequent during the three month period ended September 30, 2021, the Company obtained a legal opinion supporting its position that these charges were egregious, and reversed the liability on its balance sheet The Company intends to litigate this amount as well as the validity of the principal and interest outstanding, if a settlement on a vastly reduced amount, cannot be reached. (b) During the year ended December 31, 2021, GHS Investments funded an 8 %, $ 165,000 convertible promissory note maturing on November 16, 2021. This note is past due as of the date of this Report. The Company has continued accruing interest and no notice of default has been sent to the Company by GHS. The Company is currently negotiating with GHS to convert this loan to some form of Equity. The conversion price on the Note is fixed at $ 0.0171 . As of March 31, 2022, $ 73,204 of these notes due to one lender are past due. This lender is associated with Golock and the Company is disputing the validity of this note. Summary The Company considered the current FASB guidance of “Contracts in Entity’s Own Stock” which indicates that any adjustment to the fixed amount (either conversion price or number of shares) of the instrument regardless of the probability of whether or not within the issuers’ control means the instrument is not indexed to the issuer’s own stock. Accordingly, the Company determined that the conversion prices of the Notes were not a fixed amount because they were either subject to an adjustment based on the occurrence of future offerings or events or the conversion price was variable. As a result, the Company determined that the conversion features of the Notes were not considered indexed to the Company’s own stock and characterized the fair value of the conversion features as derivative liabilities upon issuance. The Company determined that upon issuance of the Notes, the initial fair value of the embedded conversion feature was recorded as debt discount offsetting the fair value of the Notes and the remainder recorded as financing costs in the Consolidated Statement of Operations.	NOTE 9 – CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE, RELATED PARTIES Convertible notes payable consist of the following: Schedule of Convertible notes payable December 31, December 31, Various Convertible Notes (a) $ 43,500 43,500 Ylimit, LLC Convertible Notes (b) - 1,336,208 Golock Capital, LLC Convertible Notes (c) 339,011 339,011 Other Convertible Notes (d) 253,203 238,203 Total Convertible Notes $ 635,714 1,956,922 Notes payable (b) On September 24, 2021, the Company and its largest creditor, Ylimit, agreed to restructure its existing 10% convertible note of $ 492,528 364,629 8 107,000 857,157 857,157 Advance from officer During the year ended December 31, 2021, the Company’s CEO advanced $ 10,000 10,000 Convertible notes During the three months ended June 30, 2021 the Company converted major portions of its convertible debt to equity. The Company converted $ 1,162,800 38,616 75,195,174 80,227 (a) In August 2014, the Company issued a series of convertible notes with various interest rates ranging up to 10 43,500 28,500 740,251 (b) On November 9, 2019 the Company and Ylimit, LLC entered into an amendment (“Ylimit Amendment One”) to the original secured convertible promissory note dated May 9, 2016 along with subsequent amendment and fundings that followed. Under the terms of Ylimit Amendment One, Ylimit extended maturity date of all outstanding convertible debt due to them by the company, to a new maturity date of February 09, 2020. Ylimit received no consideration for this amendment. By verbal agreement Ylimit increased the Company’s borrowing limits by $ 175,000 882,500 On February 9, 2020, the Company entered into another amendment with Ylimit (“Ylimit Amendment Two”) to further extend the maturity date of all of the Company’s outstanding debt to August 9, 2020 including the $ 175,000 On January 5, 2021 the Company entered into Amendment Three to extend the maturity of all notes until February 9, 2022. Ylimit received no consideration for Amendment Three. During the nine months ended September 30, 2021, Ylimit invested another $ 119,000 0.001 874,300,140 (c) From September 1, 2017 to December 31, 2017, the Company issued convertible notes to Golock Capital, LLC (“Lender”) in the aggregate principal amount of $ 191,750 10 maturity dates between September 1, 2018 and August 31, 2018. The notes are convertible into shares of the Company’s common stock at prices between $0.015 and $0.02 per share 4,804,708 0.014 191,750 19,652 On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Lender”) in the principal amount of $ 40,000 10 November 2, 2018 5,000 0.015 2,500,000 0.015 40,000 Company amended the notes above by changing the conversion feature for the aggregate notes to be convertible into shares of common stock of the Company at the lower of (i) $0.015 per share or, (ii) 58% of the lowest closing bid price in the 20 trading days prior to the day that the Lender requests conversion. 553,000 43,250 302,067 0 On April 29, 2019, Golock entered into an amendment with the Company to extend the maturity of the Notes until July 31, 2019. In return, Golock received several concessions. They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender request conversion 53,331 23,102 100,000,000 339,010 285,679 339,011 As a result Golock has assessed the Company additional penalties and interest of $ 1,172,782 (d) During the year ended December 31, 2021, GHS Investments funded an 8 165,000 0.0171 106,765 As of December 31, 2021, $ 73,204 Summary The Company considered the current FASB guidance of “Contracts in Entity’s Own Stock” which indicates that any adjustment to the fixed amount (either conversion price or number of shares) of the instrument regardless of the probability of whether or not within the issuers’ control means the instrument is not indexed to the issuer’s own stock. Accordingly, the Company determined that the conversion prices of the Notes were not a fixed amount because they were either subject to an adjustment based on the occurrence of future offerings or events or the conversion price was variable. As a result, the Company determined that the conversion features of the Notes were not considered indexed to the Company’s own stock and characterized the fair value of the conversion features as derivative liabilities upon issuance. The Company determined that upon issuance of the Notes, the initial fair value of the embedded conversion feature was recorded as debt discount offsetting the fair value of the Notes and the remainder recorded as financing costs in the Consolidated Statement of Operations.

DERIVATIVE LIABILITY

DERIVATIVE LIABILITY	9 Months Ended	12 Months Ended
DERIVATIVE LIABILITY	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
DERIVATIVE LIABILITY		NOTE 10 – DERIVATIVE LIABILITY The FASB has issued authoritative guidance whereby instruments which do not have fixed settlement provisions are deemed to be derivative instruments. The conversion prices of the Notes described in Note 6 were not a fixed amount because they were either subject to an adjustment based on the occurrence of future offerings or events or they were variable. Since the number of shares is not explicitly limited, the Company is unable to conclude that enough authorized and unissued shares are available to settle the conversion option. In accordance with the FASB authoritative guidance, the conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations. As of December 31, 2021 and 2020, the derivative liabilities were valued using probability weighted option pricing models with the following assumptions: Schedule of derivative liabilities fair value December 31, 2021 December 31, 2020 Exercise Price $ 0.0015 0.0018 Stock Price .0114 Risk-free interest rate 0.17 % Expected volatility 737.80 Expected life (in years) 1.00 Expected dividend yield 0 Fair Value: $ - 0 $ 3,156,582 The risk-free interest rate was based on rates established by the Federal Reserve Bank. The Company uses the historical volatility of its common stock to estimate the future volatility for its common stock. The expected life of the conversion feature of the notes was based on the remaining term of the notes. The expected dividend yield was based on the fact that the Company has not customarily paid dividends in the past and does not expect to pay dividends in the future.
Stage It Corp [Member]
DERIVATIVE LIABILITY	NOTE 6 – DERIVATIVE LIABILITY The FASB has issued authoritative guidance whereby instruments which do not have fixed settlement provisions are deemed to be derivative instruments. The conversion prices of the Notes described in Note 3 were not a fixed amount because they were either subject to an adjustment based on the occurrence of future offerings or events or they were variable. Since the number of shares is not explicitly limited, the Company is unable to conclude that enough authorized and unissued shares are available to settle the conversion option. In accordance with the FASB authoritative guidance, the conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations. As of September 30, 2021 and December 31, 2020 the derivative liabilities were valued using probability weighted option pricing models with the following assumptions: Schedule of derivative liabilities September 30, December 31, Exercise Price $ 1.19 $ 1.19 Stock Price $ 1.59 $ 1.59 Risk-free interest rate 0.04 % 0.10 % Expected volatility 110.45 % 94.55 % Expected life (in years) 1 1 Expected dividend yield 0 % 0 % Fair Value: $ 2,670,162 $ 2,404,981 The risk-free interest rate was based on rates established by the Federal Reserve Bank. The Company uses the historical volatility of its common stock to estimate the future volatility for its common stock. The expected life of the conversion feature of the notes was based on the remaining term of the notes. The expected dividend yield was based on the fact that the Company has not customarily paid dividends in the past and does not expect to pay dividends in the future.		NOTE 6 – DERIVATIVE LIABILITY The FASB has issued authoritative guidance whereby instruments which do not have fixed settlement provisions are deemed to be derivative instruments. The conversion prices of the Notes described in Note 3 were not a fixed amount because they were either subject to an adjustment based on the occurrence of future offerings or events or they were variable. Since the number of shares is not explicitly limited, the Company is unable to conclude that enough authorized and unissued shares are available to settle the conversion option. In accordance with the FASB authoritative guidance, the conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations. As of December 31, 2020 and 2019, the derivative liabilities were valued using probability weighted option pricing models with the following assumptions: Schedule of derivative liabilities December 31, December 31, Exercise Price $ 1.19 $ 1.19 Stock Price 1.59 $ 1.59 Risk-free interest rate 0.10 % 2.54 % Expected volatility 94.55 % 147.95 % Expected life (in years) 1 1 Expected dividend yield 0 % 0 % Fair Value: $ 2,404,981 $ 2,099,025 The risk-free interest rate was based on rates established by the Federal Reserve Bank. The Company uses the historical volatility of its common stock to estimate the future volatility for its common stock. The expected life of the conversion feature of the notes was based on the remaining term of the notes. The expected dividend yield was based on the fact that the Company has not customarily paid dividends in the past and does not expect to pay dividends in the future.

STOCKHOLDERS_ DEFICIT

STOCKHOLDERS’ DEFICIT	3 Months Ended	9 Months Ended	12 Months Ended
STOCKHOLDERS’ DEFICIT	Mar. 31, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
STOCKHOLDERS’ DEFICIT	NOTE 14 – STOCKHOLDERS’ DEFICIT Common stock The Company has authorized 2,000,000,000 shares of $ 0.0001 par value common stock. As of March 31, 2022, and December 31, 2021, there were 1,459,256,460 and 1,411,799,497 shares of common stock issued and outstanding respectively. Preferred Stock Series A On July 2, 2019, the Company filed a Certificate of Amendment (the “Charter Amendment”) to the Company’s Articles of Incorporation (as amended to date, the “Articles of Incorporation”) with the Secretary of State of the State of Nevada. The Charter Amendment increased the Company’s capitalization to 2,000,000,000 shares of Common Stock and 20,000,000 shares of Preferred Stock, of which, 5,000,000 were designated as Series A Convertible Preferred Stock. As of March 31, 2022 and 2021 the Company had 20,000,000 shares of $ 0.0001 par value preferred stock authorized and there were 4,250,579 shares of Series A Preferred Stock issued and outstanding. On May 22, 2019, the Company authorized and designated a class of Series A Convertible Preferred Stock (“Series A Preferred Stock”), in accordance with a Certificate of Designation filed with the State of Nevada (the “Series A Designation”). It subsequently issued 4,126,776 restricted shares of Series A Preferred Stock to various employees and service providers to compensate and reward them for services and to incentivize them to provide continued service to the Company. The Series A Preferred Stock receives relative rights and preferences under terms and conditions set forth in the Certificate of Designation of the Preferred Stock. Pursuant to the Series A Designation, each share of Series A Preferred Stock may be converted into 50 shares of common stock of the Company. The Series A Preferred Stockholders shall be entitled to share among dividends with the common stock shareholders of the Company on an as-converted basis. The Series A Preferred Stockholders shall vote with the common stock as a single class, on a 100 to 1 basis, such that for every share of Series A Preferred Stock held, such shares shall entitle the holder to cast 100 votes. The holders of the Series A Preferred Stock have no liquidation or redemption preference rights but get treated as common stockholders on an as converted basis. The Company believes that the issuance of the Series A Preferred Stock was exempt from the registration requirements under the Securities Act of 1933, as amended pursuant to Section 4(a)(2) of the Act in that said transaction did not involve a public solicitation and said restricted shares were issued to only a small number of employees and consultants with an ongoing relationship with the Company. As of March 31, 2022, and December 31, 2021, there were 4,250,579 shares of Series A Preferred issued and outstanding. Preferred Stock Series B On January 3, 2022, the Company authorized and designated a class of 1,600 0.0001 1,535 1,500,000 (less $130,000 in fees) in financing provided to the Company. Pursuant to the Series B Designation, each share of Series B Preferred Stock may be converted into $ 1,200 42,000 300,000 expense for the beneficial conversion feature of Series B Preferred stock. As of March 31, 2022 and December 31, 2021, there were 1,535 0 - shares of Series B Preferred outstanding, respectively Warrants In connection with the issuance of Series B Preferred Stock to the Company described in Note 14, the Company issued 133,689,840 0.01122 . A summary of warrants is as follows: Schedule of warrants Number of Weighted Balance outstanding, December 31, 2019 23,805,027 0.079 Warrants expired or forfeited - - Balance outstanding, December 31, 2020 23,805,027 0.079 Warrants expired or forfeited (8,004,708 ) - Balance outstanding and exercisable, December 31, 2021 15,800,319 $ 0.0079 Warrants granted March 31, 2022 133,689,640 $ 0.01122 Balance outstanding and exercisable, March 31, 2022 149,489,959 $ 0.0109 Information relating to outstanding warrants on March 31, 2022, summarized by exercise price, is as follows: The weighted-average remaining contractual life of all warrants outstanding and exercisable on March 31, 2022 is 4.42 years. The outstanding and exercisable warrants outstanding on March 31, 2022, had no intrinsic value.		NOTE 11 – STOCKHOLDERS’ DEFICIT On July 2, 2019, the Company filed a Certificate of Amendment (the “Charter Amendment”) to the Company’s Articles of Incorporation (as amended to date, the “Articles of Incorporation”) with the Secretary of State of the State of Nevada. The Charter Amendment increased the Company’s capitalization to 2,000,000,000 20,000,000 5,000,000 Common stock The Company has authorized 2,000,000,000 0.0001 1,411,799,497 1,211,495,162 Preferred Stock Series A As of December 31, 2021 and 2020 the Company had 20,000,000 0.0001 4,250,579 On May 22, 2019, the Company authorized and designated a class of Series A Convertible Preferred Stock (“Series A Preferred Stock”), in accordance with a Certificate of Designation filed with the State of Nevada (the “Series A Designation”). It subsequently issued 4,126,776 Pursuant to the Series A Designation, each share of Series A Preferred Stock may be converted into 50 The Company believes that the issuance of the Series A Preferred Stock was exempt from the registration requirements under the Securities Act of 1933, as amended pursuant to Section 4(a)(2) of the Act in that said transaction did not involve a public solicitation and said restricted shares were issued to only a small number of employees and consultants with an ongoing relationship with the Company. The Company determined the fair value of the preferred shares to be $ 590,129 Warrants No warrants were issued during the year ended December 31, 2021. During the year ended December 31, 2019, the Company issued 15,800,319 0.00475 36,533 A summary of warrants is as follows: Schedule of warrants Number of Weighted Balance outstanding, December 31, 2018 8,004,708 0.014 Warrants granted 15,800,319 .00475 Warrants exercised - - Warrants expired or forfeited - - Balance outstanding, December 31, 2019 23,805,027 0.079 Warrants granted - - Warrants exercised - - Balance outstanding, December 31, 2020 23,805,027 0.079 Warrants expired or forfeited (8,004,708 ) - Balance outstanding and exercisable, December 31, 2021 15,800,319 $ 0.0079 Information relating to outstanding warrants on December 31, 2021, summarized by exercise price, is as follows: Schedule of warrants outstanding and related prices Outstanding and Exercisable Exercise Price Per Share Shares Life (Years) Weighted Average $ 0.004750 15,800,319 1.883 $ 0.00475 The weighted-average remaining contractual life of all warrants outstanding and exercisable on December 31, 2021 is 2.08
Stage It Corp [Member]
STOCKHOLDERS’ DEFICIT		NOTE 7 – STOCKHOLDERS’ DEFICIT Common stock The Company has authorized 20,000,000 972,614 Preferred stock As of September 30, 2021 and December 31, 2021, the Company had four classes of non-redeemable Preferred stock $0.0001 Preferred A, Preferred A-1, Preferred A-2, and Preferred A-3, all with a par value of $0.0001. The number of Preferred Shares authorized and issued and outstanding are as follows: Preferred A 400,000 40,000 Preferred A-1 3,000,000 246,543 Preferred A-2 2,000,000 200,000 Preferred A-3 300,000 196,522 Each share of preferred stock is convertible to common stock on a 1 for 1 basis		NOTE 7 – STOCKHOLDERS’ DEFICIT Common stock The Company has authorized 20,000,000 972,614 Preferred stock As of December 31, 2020 and December 19, 2020, the Company had four classes of non-redeemable Preferred stock $ 0.0001 0.0001 Preferred A 400,000 40,000 Preferred A-1 3,000,000 246,543 Preferred A-2 2,000,000 200,000 Preferred A-3 300,000 196,522 Each share of preferred stock is convertible to common stock on a 1 for 1 basis

COMMITMENT AND CONTINGENCIES

COMMITMENT AND CONTINGENCIES	3 Months Ended	9 Months Ended	12 Months Ended
COMMITMENT AND CONTINGENCIES	Mar. 31, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
COMMITMENT AND CONTINGENCIES	NOTE 15 – COMMITMENT AND CONTINGENCIES Joint Venture Agreement – Music Reports, Inc. On September 1, 2018, the Company entered into an initial joint venture (“JV”) agreement with Music Reports, Inc., (“MRI”). Music Reports (musicreports.com) will initially partner with VNUE to provide Performing Rights Organization (PRO) data to VNUE’s Soundstr MRT (music recognition technology) platform through its extensive Songdex database, and will eventually work with VNUE to integrate the automated direct licensing capability and royalty payment and distribution into the Soundstr platform. The initial term of the JV is for nine (6) months and requires the Company to Pay MRI fifty percent (50%) of net revenue every quarter. As of March 31, 2022, no net revenue was generated from the JV. Artist Agreement On October 27, 2015, the Company entered into an Artist Agreement with I Break Horses, a Swedish duo based in Stockholm. The Artist Agreement is effective October 27, 2015, and has a term lasting as long as I Break Horses artist recordings are available via the VNUE Service. Under the terms of the Artist Agreement, the Company shall handle rights clearing and distribution for I Break Horses recordings and receive 30% of the Net Income generated thereby. As of March 31, 2022, the Company had not earned any revenue under this agreement. Litigation In the matter of VNUE, Inc. v. Power Up Lending Group, Ltd. On October 6, 2021, the Company commenced an action against Power Up Lending Group, Ltd. “Power Up”) and Curt Kramer (“Kramer”) (Power Up and Kramer together, the “Power Up Parties”) in the United States District Court for the Eastern District of New York. The complaint alleges that: (1) Power Up is an unregistered dealer acting in violation of Section 15(a) of the Securities Exchange Act of 1934 (the “Act”) and, pursuant to Section 29(b) of the Act, the Company is entitled to recessionary relief from certain convertible promissory notes (“Notes”) and securities purchase agreements (“SPAs”) entered into by the Company and Power Up; (2) Kramer is liable to the Company as the control person of Power Up pursuant to Section 20(a) of the Act; and (3) Power Up is liable to the Company for unjust enrichment arising from the Notes and SPAs. On December 10, 2021, the Power Up Parties filed their pre-motion conference request letter with the Court regarding their forthcoming motion to dismiss the Company’s complaint. On December 17, 2021, the Company filed its opposition thereto. On January 26, 2022, the Company filed its amended complaint, which asserted the same causes of action set forth in the initial complaint, and further alleged that that Power Up made material misstatements in connection with the purchase and sale of the Company’s securities in violation of Section 10(b) of the Act and, thus, the Company is entitled to recessionary relief from the Notes and SPAs pursuant to Section 29(b) of the Act. On February 9, 2022, the Court ordered an initial conference. The initial conference is currently scheduled for May 16, 2022, at 12:00 p.m. (EST). As of the date hereof, the Company intends to litigate its claims for relief against the Power Up Parties. Golock Capital, LLC and DBW Investments, LLC v. VNUE, Inc. On September 29, 2021, Golock Capital, LLC (“Golock”) and DBW Investments, LLC (“DBW”) (Golock and DBW together, the “Golock Plaintiffs”) commenced an action against the Company in the United States District Court for the Southern District of New York. The Golock Plaintiffs’ complaint alleges that the Company is in breach of certain convertible promissory notes and securities purchase agreements separately entered into with Golock and DBW, and seeks declaratory judgment, injunctive relief, and specific performance against the Company. On December 2, 2021, the Golock Plaintiffs filed their amended complaint, which asserted the same causes of action set forth in the initial complaint, and an additional cause of action for unjust enrichment. On January 19, 2022, the Company filed its answer with affirmative defenses to the amended complaint. As to its affirmative defenses, the Company asserted that the Golock Plaintiffs claims are barred because: (1) the Golock Plaintiffs are unregistered dealers acting in violation of Section 15(a) of the Securities Exchange Act of 1934 (the “Act”), and, pursuant to Section 29(b) of the Act, that the Company is entitled to recessionary relief from the certain convertible promissory notes and securities purchase agreements at issue in the amended complaint; and (2) that the convertible promissory notes are, in fact, criminally usurious loans that impose interest onto the Company at a rate that violates New York Penal Law § 190.40 and, therefore, the subject convertible notes are void ab initio pursuant to New York’s usury laws. On January 20, 2022, the Court ordered that the parties submit a joint letter in lieu of a pretrial conference on or before February 3, 2022. As of the date hereof, the Company intends to vigorously defend itself against the Golock Plaintiffs claims and has not recorded any liability for Golock’s claims.		NOTE 12 – COMMITMENT AND CONTINGENCIES Joint Venture Agreement – Music Reports, Inc. On September 1, 2018, the Company entered into an initial joint venture (“JV”) agreement with Music Reports, Inc., (“MRI”). Music Reports (musicreports.com) will initially partner with VNUE to provide Performing Rights Organization (PRO) data to VNUE’s Soundstr MRT (music recognition technology) platform through its extensive Songdex database, and will eventually work with VNUE to integrate automated direct licensing capability and royalty payment and distribution into the Soundstr platform. The initial term of the JV is for nine (6) months and requires the Company to Pay MRI fifty percent (50%) of net revenue every quarter. As of December 31, 2020, no net revenue was generated from the JV. Artist Agreement On October 27, 2015, the Company entered into an Artist Agreement with I Break Horses, a Swedish duo based in Stockholm. The Artist Agreement is effective October 27, 2015, and has a term lasting as long as I Break Horses artist recordings are available via the VNUE Service. Under the terms of the Artist Agreement, the Company shall handle rights clearing and distribution for I Break Horses recordings and receive 30% of the Net Income generated thereby Litigation In the matter of VNUE, Inc. v. Power Up Lending Group, Ltd. On October 6, 2021, the Company commenced an action against Power Up Lending Group, Ltd. “Power Up”) and Curt Kramer (“Kramer”) (Power Up and Kramer together, the “Power Up Parties”) in the United States District Court for the Eastern District of New York. The complaint alleges that: (1) Power Up is an unregistered dealer acting in violation of Section 15(a) of the Securities Exchange Act of 1934 (the “Act”) and, pursuant to Section 29(b) of the Act, the Company is entitled to recessionary relief from certain convertible promissory notes (“Notes”) and securities purchase agreements (“SPAs”) entered into by the Company and Power Up; (2) Kramer is liable to the Company as the control person of Power Up pursuant to Section 20(a) of the Act; and (3) Power Up is liable to the Company for unjust enrichment arising from the Notes and SPAs. On December 10, 2021, the Power Up Parties filed their pre-motion conference request letter with the Court regarding their forthcoming motion to dismiss the Company’s complaint. On December 17, 2021, the Company filed its opposition thereto. On January 26, 2022, the Company filed its amended complaint, which asserted the same causes of action set forth in the initial complaint, and further alleged that that Power Up made material misstatements in connection with the purchase and sale of the Company’s securities in violation of Section 10(b) of the Act and, thus, the Company is entitled to recessionary relief from the Notes and SPAs pursuant to Section 29(b) of the Act. On February 9, 2022, the Court ordered an initial conference. The initial conference is currently scheduled for May 16, 2022, at 12:00 p.m. (EST). As of the date hereof, the Company intends to litigate its claims for relief against the Power Up Parties. Golock Capital, LLC and DBW Investments, LLC v. VNUE, Inc. On September 29, 2021, Golock Capital, LLC (“Golock”) and DBW Investments, LLC (“DBW”) (Golock and DBW together, the “Golock Plaintiffs”) commenced an action against the Company in the United States District Court for the Southern District of New York. The Golock Plaintiffs’ complaint alleges that the Company is in breach of certain convertible promissory notes and securities purchase agreements separately entered into with Golock and DBW, and seeks declaratory judgment, injunctive relief, and specific performance against the Company. On December 2, 2021, the Golock Plaintiffs filed their amended complaint, which asserted the same causes of action set forth in the initial complaint, and an additional cause of action for unjust enrichment. On January 19, 2022, the Company filed its answer with affirmative defenses to the amended complaint. As to its affirmative defenses, the Company asserted that the Golock Plaintiffs claims are barred because: (1) the Golock Plaintiffs are unregistered dealers acting in violation of Section 15(a) of the Securities Exchange Act of 1934 (the “Act”), and, pursuant to Section 29(b) of the Act, that the Company is entitled to recessionary relief from the certain convertible promissory notes and securities purchase agreements at issue in the amended complaint; and (2) that the convertible promissory notes are, in fact, criminally usurious loans that impose interest onto the Company at a rate that violates New York Penal Law § 190.40 and, therefore, the subject convertible notes are void ab initio pursuant to New York’s usury laws. On January 20, 2022, the Court ordered that the parties submit a joint letter in lieu of a pretrial conference on or before February 3, 2022. As of the date hereof, the Company intends to vigorously defend itself against the Golock Plaintiffs claims and has not recorded any liability for Golock’s claims.
Stage It Corp [Member]
COMMITMENT AND CONTINGENCIES		NOTE 8 – COMMITMENT AND CONTINGENCIES The Company had no		NOTE 8 – COMMITMENT AND CONTINGENCIES The Company had no

INCOME TAXES

INCOME TAXES	12 Months Ended
INCOME TAXES	Dec. 31, 2021
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 13 – INCOME TAXES Reconciliation between the expected federal income tax rate and the actual tax rate is as follows: Schedule of federal income tax rate and the actual tax rate Year Ended 2021 2020 Federal statutory tax rate 21 % 21 % State tax, net of federal benefit 6 % 6 % Total tax rate 27 % 27 % Allowance ( 27 )% ( 27 )% Effective tax rate - % - % The following is a summary of the deferred tax assets: Summary of deferred tax assets Year Ended 2021 2020 Net operating loss carryforwards $ 3,418,000 $ 3,060,000 Valuation allowance (3,418,000 ) (3,060,000 ) Net deferred tax asset $ - $ - The Company has no tax provision for any period presented due to our history of operating losses. As of December 31, 2021, the Company had estimated net operating loss carry forwards of approximately $ 12,662,000 through 2032 The Company adopted accounting rules which address the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under these rules, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. These accounting rules also provide guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. As of December 31, 2017 no

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended	9 Months Ended	12 Months Ended
SUBSEQUENT EVENTS	Mar. 31, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
SUBSEQUENT EVENTS	NOTE 16 – SUBSEQUENT EVENTS On April 19, 2022, the Company entered a Securities Purchase Agreement with GHS whereby GHS agreed to purchase, Two Hundred and Fifty Thousand Dollars ($250,000) of the Company’s Series B Convertible Preferred Stock in exchange for Two Hundred and Fifty (250) shares of Series B Convertible Preferred Stock. The Company issued to GHS commitment shares of Ten (10) shares of Series B Convertible Preferred Stock and a warrant (the “Warrant”) to purchase the number of shares of common stock issuable upon conversion of the Series B Convertible Preferred Stock (the “Warrant Shares”). The Company has agreed to register the shares of common stock issuable pursuant to the conversion of the Series B Convertible Preferred Stock and the Warrant Shares. In connection with this issuance, the Company amended and restated its Certificate of Designation increasing the authorized Series B shares from 1,600 shares to 2,500 shares. Additionally, subsequent to March 31, 2022 the Company issued 15,229,816		NOTE 14 – SUBSEQUENT EVENTS On February 13, 2022, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with VNUE Acquisition Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“MergerCo”), Stage It Corp., a Delaware corporation (“Stage It”), and the stockholders’ representative for Stage It, pursuant to which the Company will acquire Stage It for up to $10 million (the “Merger Consideration”), by merging MergerCo with and into Stage It, with Stage It continuing as the surviving entity and wholly-owned subsidiary of the Company (the “Merger”). Through the period ended March 17, 2022 the Company had spent approximately $ 1,414,000 Pursuant to the Merger Agreement, and subject to the terms and conditions set forth therein, at the closing of the Merger (the “Closing”), each of Stage It’s outstanding shares (including common and preferred shares) will be converted into the right to receive the applicable portion of the Merger Consideration. A portion of the Merger Consideration will be paid in cash and take the form of satisfying certain outstanding debt obligations of Stage It, as outlined in a Closing Payment Certificate of the Merger Agreement, and the other portion will be paid in shares of the Company’s common stock or preferred stock, with the actual number of such shares to be issued reduced by the cash component outlaid in the transaction. A portion of the Merger Consideration, $1 million, will be held back for the purposes of satisfying certain contingent obligations of Stage It. The Merger Agreement also allows for the issuance of earn out shares, not to exceed the overall Merger Consideration, provided that certain EBIDTA requirements are met over the course of 18 months.
Stage It Corp [Member]
SUBSEQUENT EVENTS		NOTE 9 – SUBSEQUENT EVENTS On February 13, 2022, the Company entered into an agreement with VNUE, Inc. to sell 100 % of the ownership of the Company in a $ 10,000,000 stock transaction comprised of approximately $ 1,500,000 in cash and up to $ 8,500,000 in restricted VNUE common stock, some of which is milestone based.		NOTE 9 – SUBSEQUENT EVENTS Subsequent to December 31, 2020 the Company received $ 700,922 in proceeds comprised of a promissory loan for $ 250,000 at 15 % interest, advances from VNUE of $ 35,000 and $ 415,922 under the terms of revenue factoring agreement with three different lenders at an average rate of 18% On February 13, 2022, the Company entered into an agreement with VNUE, Inc. to sell 100 % of the ownership of the Company in a $ 10,000,000 stock transaction comprised of approximately $ 1,500,000 in cash and up to $ 8,500,000 in restricted VNUE common stock, some of which is milestone based.

NOTES PAYABLE -PAST DUE

NOTES PAYABLE -PAST DUE	12 Months Ended
NOTES PAYABLE -PAST DUE	Dec. 31, 2020
Stage It Corp [Member]
NOTES PAYABLE -PAST DUE	NOTE 5 – NOTES PAYABLE -PAST DUE As of December 31, 2020 and 2019 the Company had $ 179,000 547,500 315,000 18 275,000 10

GONING CONCERN

GONING CONCERN	3 Months Ended
GONING CONCERN	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GONING CONCERN	NOTE 2 – GONING CONCERN The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, during the three months ended March 31, 2022, the Company had cash on hand of $ 60,458 , used cash in operations of $ 248,739 , and had an accumulated deficit of $ 15,028,400 as of March 31, 2022. In addition, the Company had negative working capital of $ 14,595,097 . These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date of the financial statements being issued. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its business plan. The Company does not have any commitments for additional capital. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. In addition, the Company’s independent registered public accounting firm, in its report on the Company’s March 31, 2022, consolidated financial statements, has raised substantial doubt about the Company’s ability to continue as a going concern. The continuation of the Company as a going concern is dependent upon its ability to obtain necessary debt or equity financing to continue operations until it begins generating positive cash flow. Historically, the Company has been able to fund its operations from the proceeds of notes payable and convertible notes. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company can obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in the case of equity financing.

BUSINESS ACQUISITION

BUSINESS ACQUISITION	3 Months Ended
BUSINESS ACQUISITION	Mar. 31, 2022
Business Combination and Asset Acquisition [Abstract]
BUSINESS ACQUISITION	NOTE 6 – BUSINESS ACQUISITION On February 13, 2022, VNUE, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with VNUE Acquisition Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“MergerCo”), Stage It Corp., a Delaware corporation (“Stage It”), and the stockholders’ representative for Stage It, pursuant to which the Company will acquire Stage It for up to $10 million (the “Merger Consideration”), by merging MergerCo with and into Stage It, with Stage It continuing as the surviving entity and wholly owned subsidiary of the Company (the “Merger”). Pursuant to the Merger Agreement, and subject to the terms and conditions set forth therein, at the closing of the Merger (the “Closing”), each of Stage It’s outstanding shares (including common and preferred shares) will be converted into the right to receive the applicable portion of the Merger Consideration. A portion of the Merger Consideration will be paid in cash and take the form of satisfying certain outstanding debt obligations of Stage It, as outlined in a Closing Payment Certificate of the Merger Agreement, and the other portion will be paid in shares of the Company’s common stock or preferred stock, with the actual number of such shares to be issued reduced by the cash component outlaid in the transaction. A portion of the Merger Consideration, $1 million, will be held back to satisfy certain contingent obligations of Stage It. The Merger Agreement also allows for the issuance of earn-out shares, not to exceed the overall Merger Consideration, provided that certain EBIDTA requirements are met over the course of 18 months. On February 13, 2022, the Company, Stage It and the shareholders of Stage It entered into a voting agreement concerning the Merger. On February 14, 2022, the Company completed the acquisition of Stage It. As a result of the Closing, Stage It became a wholly-owned subsidiary of the Company. For the acquisition, the Company will issue the initial 135,000,000 shares and pay certain amounts as detailed under Merger Consideration in the Merger Agreement. The price to be paid in cash and stock for the Earnout Shares and Holdback Shares are set forth in the Merger Agreement. The Merger Agreement has been included to provide investors with information regarding its terms. The representations, warranties, and covenants contained in the Merger Agreement were made only for the purposes of the Merger Agreement, were made as of specific dates, were made solely for the benefit of the parties to the Merger Agreement, and may not have been intended to be statements of fact, but rather as a method of allocating risk and governing the contractual rights and relationships among the parties to the Merger Agreement. In addition, such representations, warranties, and covenants may have been qualified by certain disclosures not reflected in the text of the Merger Agreement and may apply standards of materiality and other qualifications and limitations in a way that is different from what may be viewed as material by the Company’s shareholders. None of the Company’s shareholders or any other third party should rely on the representations, warranties, and covenants, or any descriptions thereof, as characterizations of the actual state of facts or conditions of the Company, the Company, Merger Sub, or any of their respective subsidiaries or affiliates For the acquisition of Stage It the following table summarizes the acquisition date fair value of the consideration paid, identifiable assets acquired and liabilities assumed: Consideration paid Schedule of fair value of consideration Common stock issued, 41,476,963 shares of the Company’s restricted common stock valued at $0.0101 per share $ 418,917 Common stock issuable, 93,523,037 shares of the Company’s restricted common stock valued at $0.0101 per share 944,583 Net liabilities assumed 2,871,066 Earnout liability 7,679,984 Cash paid 1,085,450 Fair value of total consideration paid $ 13,000,000 Net assets acquired and liabilities assumed Schedule of net asset acquired and liabilities assumed Cash and cash equivalents $ 107,689 Property 36,882 Total assets 144,571 Accounts payable and accrued liabilities 1,711,349 Notes payable 526,385 Deferred revenue 777,903 Total liabilities $ 3,015,637 Net liabilities assumed $ 2,871,066 The Company has allocated the fair value of the total consideration paid of $ 10,400,000 to goodwill and $ 2,600,000 to intangible assets with a life of three years. The value of goodwill represents Stage It’s ability to generate profitable operations going forward. Management estimated the provisional fair values of the intangible assets and goodwill on March 31, 2022. The Company’s accounting for the acquisition of Stage It is incomplete. Management is performing a valuation study to calculate the fair value of the acquired intangible assets, which it plans to complete within the one-year measurement period.

INTANGIBLE ASSETS

INTANGIBLE ASSETS	3 Months Ended
INTANGIBLE ASSETS	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS	NOTE 7 – INTANGIBLE ASSETS As of March 31, 2022, the balance of intangible assets was $ 2,491,677 108,333 in amortization expense. As discussed in Note 6, the intangible assets have been valued based on provisional estimates of fair value and are subject to change as the Company completes its valuation assessment by the completion of the one-year measurement period. Amortization for the following fiscal years is estimated to be: 2022 - $ 650,000 ; 2023 - $ 866,666 ; and 2024 - $ 866,666 , 2025 -$ 216,668 .

CONVERTIBLE NOTES PAYABLE

CONVERTIBLE NOTES PAYABLE	3 Months Ended	12 Months Ended
CONVERTIBLE NOTES PAYABLE	Mar. 31, 2022	Dec. 31, 2021
Debt Disclosure [Abstract]
CONVERTIBLE NOTES PAYABLE	NOTE 12 – CONVERTIBLE NOTES PAYABLE Convertible notes payable consist of the following: Schedule of Convertible notes payable March 31, December 31, Various Convertible Notes $ 43,500 43,500 Golock Capital, LLC Convertible Notes (a) 339,011 339,011 Other Convertible Notes (b) 256,203 253,203 Total Convertible Notes $ 638,714 635,714 (a) On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Lender”) in the principal amount of $ 40,000 with an interest rate at 10 % per annum and a maturity date of November 2, 2018 . The note included an original issue discount of $5,000. The note is convertible into shares of the Company’s common stock at $ 0.015 per share. As additional consideration for the Lender to enter into this agreement with the Company, the Company issued warrants to the Lender to acquire in the aggregate 2,500,000 shares of the Company’s common stock at an exercise price of $0.015 per share that expire three years from the date of grant. The relative fair value of the warrants, the original issue discount, and the beneficial conversion feature totaling $ 40,000 was recorded as a debt discount and will be amortized to interest expense over the term of the note. On November 5, 2018, the Company amended the notes above by changing the conversion feature for the aggregate notes to be convertible into shares of common stock of the Company at the lower of (i) $0.015 per share or, (ii) 58% of the lowest closing bid price in the 20 trading days prior to the day that the Lender requests conversion. This feature gave rise to a derivative liability of $ 553,000 at the date of issuance as discussed below. The amendment also increased the principal face amount of notes to include accrued interest, and an additional $ 43,250 was added to principal, which was recorded to financing costs. The aggregate balance of the notes outstanding, and the related debt discount was $ 302,067 and $ 0 , respectively, as of December 31, 2018. On April 29, 2019, Golock entered into an amendment with the Company to extend the maturity of the Notes until July 31, 2019. In return, Golock received several concessions. They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender requested conversion. During the year ending December 31, 2019, the Company issued new notes payable of $ 53,331 and $ 23,102 of notes and accrued interest were converted into 100,000,000 shares of common stock. The balance of the notes outstanding on December 31, 2019, was $ 339,010 . As of December 31, 2019, $ 285,679 of these notes were past due. As of March 31, 2022 all of the Golock notes amounting to $ 339,011 were past due. As a result Golock has assessed the Company additional penalties and interest of $ 1,172,782 . The Company disagrees with the accrued interest and penalties due to Golock. Initially, the Company recorded this amount as a liability on its balance during the period ended March 31, 2021. Subsequent during the three month period ended September 30, 2021, the Company obtained a legal opinion supporting its position that these charges were egregious, and reversed the liability on its balance sheet The Company intends to litigate this amount as well as the validity of the principal and interest outstanding, if a settlement on a vastly reduced amount, cannot be reached. (b) During the year ended December 31, 2021, GHS Investments funded an 8 %, $ 165,000 convertible promissory note maturing on November 16, 2021. This note is past due as of the date of this Report. The Company has continued accruing interest and no notice of default has been sent to the Company by GHS. The Company is currently negotiating with GHS to convert this loan to some form of Equity. The conversion price on the Note is fixed at $ 0.0171 . As of March 31, 2022, $ 73,204 of these notes due to one lender are past due. This lender is associated with Golock and the Company is disputing the validity of this note. Summary The Company considered the current FASB guidance of “Contracts in Entity’s Own Stock” which indicates that any adjustment to the fixed amount (either conversion price or number of shares) of the instrument regardless of the probability of whether or not within the issuers’ control means the instrument is not indexed to the issuer’s own stock. Accordingly, the Company determined that the conversion prices of the Notes were not a fixed amount because they were either subject to an adjustment based on the occurrence of future offerings or events or the conversion price was variable. As a result, the Company determined that the conversion features of the Notes were not considered indexed to the Company’s own stock and characterized the fair value of the conversion features as derivative liabilities upon issuance. The Company determined that upon issuance of the Notes, the initial fair value of the embedded conversion feature was recorded as debt discount offsetting the fair value of the Notes and the remainder recorded as financing costs in the Consolidated Statement of Operations.	NOTE 9 – CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE, RELATED PARTIES Convertible notes payable consist of the following: Schedule of Convertible notes payable December 31, December 31, Various Convertible Notes (a) $ 43,500 43,500 Ylimit, LLC Convertible Notes (b) - 1,336,208 Golock Capital, LLC Convertible Notes (c) 339,011 339,011 Other Convertible Notes (d) 253,203 238,203 Total Convertible Notes $ 635,714 1,956,922 Notes payable (b) On September 24, 2021, the Company and its largest creditor, Ylimit, agreed to restructure its existing 10% convertible note of $ 492,528 364,629 8 107,000 857,157 857,157 Advance from officer During the year ended December 31, 2021, the Company’s CEO advanced $ 10,000 10,000 Convertible notes During the three months ended June 30, 2021 the Company converted major portions of its convertible debt to equity. The Company converted $ 1,162,800 38,616 75,195,174 80,227 (a) In August 2014, the Company issued a series of convertible notes with various interest rates ranging up to 10 43,500 28,500 740,251 (b) On November 9, 2019 the Company and Ylimit, LLC entered into an amendment (“Ylimit Amendment One”) to the original secured convertible promissory note dated May 9, 2016 along with subsequent amendment and fundings that followed. Under the terms of Ylimit Amendment One, Ylimit extended maturity date of all outstanding convertible debt due to them by the company, to a new maturity date of February 09, 2020. Ylimit received no consideration for this amendment. By verbal agreement Ylimit increased the Company’s borrowing limits by $ 175,000 882,500 On February 9, 2020, the Company entered into another amendment with Ylimit (“Ylimit Amendment Two”) to further extend the maturity date of all of the Company’s outstanding debt to August 9, 2020 including the $ 175,000 On January 5, 2021 the Company entered into Amendment Three to extend the maturity of all notes until February 9, 2022. Ylimit received no consideration for Amendment Three. During the nine months ended September 30, 2021, Ylimit invested another $ 119,000 0.001 874,300,140 (c) From September 1, 2017 to December 31, 2017, the Company issued convertible notes to Golock Capital, LLC (“Lender”) in the aggregate principal amount of $ 191,750 10 maturity dates between September 1, 2018 and August 31, 2018. The notes are convertible into shares of the Company’s common stock at prices between $0.015 and $0.02 per share 4,804,708 0.014 191,750 19,652 On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Lender”) in the principal amount of $ 40,000 10 November 2, 2018 5,000 0.015 2,500,000 0.015 40,000 Company amended the notes above by changing the conversion feature for the aggregate notes to be convertible into shares of common stock of the Company at the lower of (i) $0.015 per share or, (ii) 58% of the lowest closing bid price in the 20 trading days prior to the day that the Lender requests conversion. 553,000 43,250 302,067 0 On April 29, 2019, Golock entered into an amendment with the Company to extend the maturity of the Notes until July 31, 2019. In return, Golock received several concessions. They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender request conversion 53,331 23,102 100,000,000 339,010 285,679 339,011 As a result Golock has assessed the Company additional penalties and interest of $ 1,172,782 (d) During the year ended December 31, 2021, GHS Investments funded an 8 165,000 0.0171 106,765 As of December 31, 2021, $ 73,204 Summary The Company considered the current FASB guidance of “Contracts in Entity’s Own Stock” which indicates that any adjustment to the fixed amount (either conversion price or number of shares) of the instrument regardless of the probability of whether or not within the issuers’ control means the instrument is not indexed to the issuer’s own stock. Accordingly, the Company determined that the conversion prices of the Notes were not a fixed amount because they were either subject to an adjustment based on the occurrence of future offerings or events or the conversion price was variable. As a result, the Company determined that the conversion features of the Notes were not considered indexed to the Company’s own stock and characterized the fair value of the conversion features as derivative liabilities upon issuance. The Company determined that upon issuance of the Notes, the initial fair value of the embedded conversion feature was recorded as debt discount offsetting the fair value of the Notes and the remainder recorded as financing costs in the Consolidated Statement of Operations.

SIGNIFICANT AND CRITICAL ACCO_2

SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES (Policies)	3 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Basis of Consolidation	Basis of Consolidation The accompanying financial statements have been prepared in accordance with the Financial Accounting Standards Board (“ FASB Codification GAAP The Company consolidates its results with its wholly-owned subsidiary, Stage It Corp.		Basis of Consolidation The Company consolidates all wholly-owned and majority-owned subsidiaries in which the Company’s power to control exists. The Company consolidates the following subsidiaries and/or entities: Schedule of subsidiaries and/or entities Name of consolidated subsidiary or Entity State or other jurisdiction of incorporation or organization Date of incorporation or formation (date of acquisition/ disposition, if applicable) Attributable interest VNUE Inc. (formerly TGRI) The State of Nevada April 4, 2006 100 % VNUE Inc. (VNUE Washington) The State of Washington October 16, 2014 100 % VNUE LLC The State of Washington August 1, 2013 100 %
Revenue Recognition	Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts Stage It receives revenue through a percentage of ticket sales and tipping. This show-based revenue creates a pool that is shared with the performing artist. Once a show is completed the revenue that has been created through tickets and tips is allocated. Typically, Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer, however, there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as an agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production. The Company also recognizes revenue on the sale of CDs and USB drives that contain the recording of live concerts and are made available to concert attendees immediately after the show and online. Revenue is recognized on the sale of a product when our performance obligation is completed which is when the risk of loss transfers to our customers and the collection of the receivable is reasonably assured, which generally occurs when the product is purchased. As of March 31, 2022 and December 31, 2021 deferred revenue amounted to $ 857,326 and $ 74,225 , respectively.		Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts The Company recognizes revenue on the sale CDs and USB drives that contain the recording of live concerts and made available to concert attendees immediately after the show and on-line. Revenue is recognized on the sale of a product when our performance obligation is completed which is when the risk of loss transfers to our customers and the collection of the receivable is reasonably assured, which generally occurs when the product is purchased.
Use of Estimates	Use of Estimates The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the assumptions used for the determination of goodwill and intangible assets, the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates.		Use of Estimates The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the assumptions used for impairment testing of intangible assets, assumptions used to value the derivative liabilities, the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.		Fair Value of Financial Instruments The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates. The fair value of the derivative liabilities of $- 0 3,156,582
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date.		Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date.
Income (Loss) per Common Share			Income (Loss) per Common Share Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options. No 15,800,319 11,313,852
Intangible Assets			Intangible Assets The Company accounts for intangible assets in accordance with the authoritative guidance issued by the FASB. Intangibles are valued at their fair market value and are amortized taking into account the character of the acquired intangible asset and the expected period of benefit. The Company evaluates intangible assets for impairment, at a minimum, on an annual basis and whenever events or changes in circumstances indicate that the carrying value may not be recoverable from its estimated undiscounted future cash flows. Recoverability of intangible assets is measured by comparing their net book value to the related projected undiscounted cash flows from these assets, considering a number of factors, including past operating results, budgets, economic projections, market trends, and product development cycles. If the net book value of the asset exceeds the related undiscounted cash flows, the asset is considered impaired, and a second test is performed to measure the amount of impairment loss. As of December 31, 2020 based on the assessment of Management, the Company determined that its intangible asset had been impaired.
Segments			Segments The Company operates in one segment for the manufacture and distribution of our products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in economic characteristics; nature of products and services; and procurement, manufacturing, and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position or results of operations.		Recently Issued Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position or results of operations. The Company adopted ASC 842 on January 1, 2019. However, the adoption of the standard had no impact on the Company’s financial statements since all Company leases are month to month, or short-term rentals.
Property and Equipment	Property and Equipment Property and equipment are stated at cost or fair value if acquired as part of a business combination. Depreciation is computed by the straight-line method and is charged to operations over the estimated useful lives of the assets. The threshold for depreciating office equipment is $ 200 , and $ 1,000 for furniture and fixtures Maintenance and repairs are charged to expense as incurred. The carrying amount and accumulated depreciation of assets sold or retired are removed from the accounts in the year of disposal and any resulting gain or loss is included in the results of operations. The estimated useful lives of property and equipment are as follows: Schedule of estimated useful lives of property and equipment Computers, software, and office equipment 3 years Furniture and fixtures 7 years As of March 31, 2022, the Company’s property, which consisted solely of computers, amounted to $ 35,002 and - 0 -, respectively. Depreciation expense for the three months ended March 31, 2022, and 2021, amounted to $ 1,880 and $- 0 -, respectively.
Management’s Representation of Interim Financial Statements	Management’s Representation of Interim Financial Statements The accompanying unaudited financial statements have been prepared by the Company without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and disclosures normally included in financial statements prepared in accordance with GAAP have been or omitted as allowed by such rules and regulations, and management believes that the disclosures are adequate to make the information presented not misleading. These financial statements include all of the adjustments, which in the opinion of management are necessary to a fair presentation of financial position and results of operations. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results for a full year.
Stock Purchase Warrants	Stock Purchase Warrants The Company accounts for warrants issued to purchase shares of its common stock as equity in accordance with FASB ASC 480, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock, Distinguishing Liabilities from Equity.
Income (Loss) per Common Share	Income (Loss) per Common Share Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that is then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on March 31, 2022, because their impact was anti-dilutive. As of March 31, 2022, the Company had 149,489,159 outstanding warrants and 20,333,526 shares related to convertible notes payables respectively, which were excluded from the computation of net loss per share.
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized. The goodwill arising from the Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets consist primarily of customer relationships, trademarks, and product formulations. The useful life of these customer relationships is estimated to be three years. Goodwill is not amortized but is subject to annual impairment testing unless circumstances dictate more frequent assessments. The Company performs an annual impairment assessment for goodwill during the fourth quarter of each year and more frequently whenever events or changes in circumstances indicate that the fair value of the asset may be less than the carrying amount. Goodwill impairment testing compares the fair value of the reporting unit to its carrying amount. The fair value of the reporting unit is determined by considering both the income approach and market approaches. The fair values calculated under the income approach and market approaches are weighted based on circumstances surrounding the reporting unit. Under the income approach, the Company determines fair value based on estimated future cash flows of the reporting unit, which are discounted to the present value using discount factors that consider the timing and risk of cash flows. For the discount rate, the Company relies on the capital asset pricing model approach, which includes an assessment of the risk-free interest rate, the rate of return from publicly traded stocks, the Company’s risk relative to the overall market, the Company’s size and industry and other Company-specific risks. Other significant assumptions used in the income approach include the terminal value, growth rates, future capital expenditures, and changes in future working capital requirements. The market approaches use key multiples from guideline businesses that are comparable and are traded on a public market. If the fair value of the reporting unit is greater than its carrying amount, there is no impairment. If the reporting unit’s carrying amount exceeds its fair value, then an impairment loss is recognized in an amount equal to the excess.
Stage It Corp [Member]
Revenue Recognition		Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts Stage It receives revenue through a percentage of ticket sales and tipping. This show-based revenue creates a pool that is shared with the performing artist. Once a show is completed the revenue that has been created through tickets and tips is allocated. Typically, Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer, however there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production.		Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts Stage It receives revenue through a percentage of ticket sales and tipping. This show-based revenue creates a pool that is shared with the performing artist. Once a show is completed the revenue that has been created through tickets and tips is allocated. Typically, Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer, however there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production.
Use of Estimates		Use of Estimates The preparation of the financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the assumptions used to value the derivative liabilities, the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates.		Use of Estimates The preparation of the financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the assumptions used to value the derivative liabilities, the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates.
Fair Value of Financial Instruments		Fair Value of Financial Instruments The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates. The fair value of the derivative liabilities of $ 2,670,163 2,404,091		Fair Value of Financial Instruments The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates. The fair value of the derivative liabilities of $ 2,404,981 2,099,025
Derivative Financial Instruments		Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date.		Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date.
Income (Loss) per Common Share		Income (Loss) per Common Share Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options and, preferred stock and convertible notes. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on September 30, 2021 and December 31, 2020 respectively, because their impact was anti-dilutive.		Income (Loss) per Common Share Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, which could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options and, preferred stock and convertible notes. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on December 31, 2020 and 2019, respectively, because their impact was anti-dilutive.
Recently Issued Accounting Pronouncements		Recently Issued Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position or results of operations.		Recently Issued Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position or results of operations.
Basis of Presentation		Basis of Presentation The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and are expressed in United States dollars. For the periods ended September 30, 2021 and December 31, 2020 the financial statements include the accounts of the Company, Stage It. Corporation.		Basis of Presentation The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and are expressed in United States dollars. For the years ended December 31, 2020 and 2019, the financial statements include the accounts of the Company, Stage It. Corporation
Property and Equipment		Property and Equipment Property and equipment are stated at cost or fair value if acquired as part of a business combination. Depreciation is computed by the straight-line method and is charged to operations over the estimated useful lives of the assets. The threshold for depreciating office equipment is $ 200 1,000 Schedule of estimated useful lives Computers, software, and office equipment 3 Furniture and fixtures 7 As of September 30, 2021 and December 31, 2020 the Company’s property which consisted solely of computers amounted to $ 60,303 62,912 17,767		Property and Equipment Property and equipment are stated at cost or fair value if acquired as part of a business combination. Depreciation is computed by the straight-line method and is charged to operations over the estimated useful lives of the assets. The threshold for depreciating office equipment is $ 200 1,000 Schedule of estimated useful lives Computers, software, and office equipment 3 Furniture and fixtures 7 As of December 31, 2020 and 2019, the Company’s property, which consisted solely of computers, amounted to $ 62,912 0 4,468 0
Management’s Representation of Interim Financial Statements		Management’s Representation of Interim Financial Statements The accompanying unaudited financial statements have been prepared by the Company without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Company uses the same accounting policies in preparing quarterly and annual financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted as allowed by such rules and regulations, and management believes that the disclosures are adequate to make the information presented not misleading. These financial statements include all of the adjustments, which in the opinion of management are necessary to a fair presentation of financial position and results of operations. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results for a full year. These financial statements should be read in conjunction with the audited financial statements and notes thereto at December 31, 2020.

SIGNIFICANT AND CRITICAL ACCO_3

SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES (Tables)	3 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Schedule of subsidiaries and/or entities			Schedule of subsidiaries and/or entities Name of consolidated subsidiary or Entity State or other jurisdiction of incorporation or organization Date of incorporation or formation (date of acquisition/ disposition, if applicable) Attributable interest VNUE Inc. (formerly TGRI) The State of Nevada April 4, 2006 100 % VNUE Inc. (VNUE Washington) The State of Washington October 16, 2014 100 % VNUE LLC The State of Washington August 1, 2013 100 %
Schedule of estimated useful lives of property and equipment	Schedule of estimated useful lives of property and equipment Computers, software, and office equipment 3 years Furniture and fixtures 7 years
Stage It Corp [Member]
Schedule of estimated useful lives		Schedule of estimated useful lives Computers, software, and office equipment 3 Furniture and fixtures 7		Schedule of estimated useful lives Computers, software, and office equipment 3 Furniture and fixtures 7

ACCOUNTS PAYABLE AND ACCRUED _2

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)	3 Months Ended	9 Months Ended	12 Months Ended
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)	Mar. 31, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Schedule of accrued liabilities	Schedule of accrued liabilities March 31, 2022 December 31, 2021 Accounts payable and accrued expense 2,298,240 $ 588,275 Accrued interest 259,179 189,527 Soundstr Obligation 145,529 145,259 Total accounts payable and accrued liabilities 2,702,948 $ 923,061		Schedule of accrued liabilities December 31, 2021 December 31, 2020 Accounts payable and accrued expense (includes $93,625 due to a former officer) $ 588,275 $ 587,230 Accrued interest 189,527 466,801 Accrued interest and penalties Golock - 1,172,782 Soundstr Obligation 145,259 145,259 Total accounts payable and accrued liabilities 923,061 $ 2,372,072
Stage It Corp [Member]
Schedule of accounts payable and accrued liabilities		Schedule of accounts payable and accrued liabilities September 30, 2021 December 31, 2020 Accounts payable $ 599,817 $ 427,086 Accrued liabilities (a)(b) 2,313,671 1,785,861 Accrued interest 840,197 650,654 Accrued interest- related parties 893,632 767,715 Total accounts payable and accrued liabilities $ 4,647,317 $ 2,404,981 (a) Includes $887,120 in liabilities due to artists, $846,477 in unredeemed outstanding notes purchased by users, and $376,703 in payroll liabilities as of September 30, 2021 (b) Includes $946,537 in liabilities due to artists and $781,172 in unredeemed outstanding notes purchased by users as of December 31, 2020		Schedule of accounts payable and accrued liabilities December 31, December 31, Accounts payable $ 427,086 $ 223,795 Accrued liabilities (a)(b) 1,785,861 699,914 Accrued interest 650,654 502,916 Accrued interest- related parties 767,715 617,891 Total accounts payable and accrued liabilities $ 2,404,981 $ 2,044,516 (a) Includes $946,537 in liabilities due to artists and $791,172 in unredeemed outstanding notes purchased by users as of December 31, 2020 (b) Includes $398,729 in liabilities due to artists and $297,795 in unredeemed outstanding notes purchased by users as of December 31, 2019

CONVERTIBLE NOTES PAYABLE AND_2

CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE, RELATED PARTIES (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Debt Disclosure [Abstract]
Schedule of Convertible notes payable	Schedule of Convertible notes payable March 31, December 31, Various Convertible Notes $ 43,500 43,500 Golock Capital, LLC Convertible Notes (a) 339,011 339,011 Other Convertible Notes (b) 256,203 253,203 Total Convertible Notes $ 638,714 635,714	Schedule of Convertible notes payable December 31, December 31, Various Convertible Notes (a) $ 43,500 43,500 Ylimit, LLC Convertible Notes (b) - 1,336,208 Golock Capital, LLC Convertible Notes (c) 339,011 339,011 Other Convertible Notes (d) 253,203 238,203 Total Convertible Notes $ 635,714 1,956,922

DERIVATIVE LIABILITY (Tables)

DERIVATIVE LIABILITY (Tables)	9 Months Ended	12 Months Ended
DERIVATIVE LIABILITY (Tables)	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Schedule of derivative liabilities		Schedule of derivative liabilities fair value December 31, 2021 December 31, 2020 Exercise Price $ 0.0015 0.0018 Stock Price .0114 Risk-free interest rate 0.17 % Expected volatility 737.80 Expected life (in years) 1.00 Expected dividend yield 0 Fair Value: $ - 0 $ 3,156,582
Stage It Corp [Member]
Schedule of derivative liabilities	Schedule of derivative liabilities September 30, December 31, Exercise Price $ 1.19 $ 1.19 Stock Price $ 1.59 $ 1.59 Risk-free interest rate 0.04 % 0.10 % Expected volatility 110.45 % 94.55 % Expected life (in years) 1 1 Expected dividend yield 0 % 0 % Fair Value: $ 2,670,162 $ 2,404,981		Schedule of derivative liabilities December 31, December 31, Exercise Price $ 1.19 $ 1.19 Stock Price 1.59 $ 1.59 Risk-free interest rate 0.10 % 2.54 % Expected volatility 94.55 % 147.95 % Expected life (in years) 1 1 Expected dividend yield 0 % 0 % Fair Value: $ 2,404,981 $ 2,099,025
Schedule of notes payable	Schedule of notes payable September 30, December 31, Notes payable (a) $ 879,722 $ 179,000 Convertible notes related party-past due (b) 547,500 547,500 Convertible notes-past due (b) 315,000 315,000 Total notes payable $ 1,742,422 $ 1,041,500 (a) Notes payable are comprised of a note for $179,000 at 15% interest in both period that is past due, a promissory note for $250,000 at 15% interest, advances of $35,000, and $415,922 in loans under the terms of revenue factoring agreement with three different lenders at an average rate of 18% (b) The Company entered into several convertible promissory notes in 2013, 2014 and 2015 with several related parties (see Note 3) and third parties. These notes were issued to fund the early growth of the Company. The notes were issued at 18% interest compound annually and can only convert to common stock upon the occurrence of a qualified funding, which has not occurred

STOCKHOLDERS_ DEFICIT (Tables)

STOCKHOLDERS’ DEFICIT (Tables)	3 Months Ended	12 Months Ended
STOCKHOLDERS’ DEFICIT (Tables)	Mar. 31, 2022	Dec. 31, 2021
Equity [Abstract]
Schedule of warrants	Schedule of warrants Number of Weighted Balance outstanding, December 31, 2019 23,805,027 0.079 Warrants expired or forfeited - - Balance outstanding, December 31, 2020 23,805,027 0.079 Warrants expired or forfeited (8,004,708 ) - Balance outstanding and exercisable, December 31, 2021 15,800,319 $ 0.0079 Warrants granted March 31, 2022 133,689,640 $ 0.01122 Balance outstanding and exercisable, March 31, 2022 149,489,959 $ 0.0109	Schedule of warrants Number of Weighted Balance outstanding, December 31, 2018 8,004,708 0.014 Warrants granted 15,800,319 .00475 Warrants exercised - - Warrants expired or forfeited - - Balance outstanding, December 31, 2019 23,805,027 0.079 Warrants granted - - Warrants exercised - - Balance outstanding, December 31, 2020 23,805,027 0.079 Warrants expired or forfeited (8,004,708 ) - Balance outstanding and exercisable, December 31, 2021 15,800,319 $ 0.0079
Schedule of warrants outstanding and related prices		Schedule of warrants outstanding and related prices Outstanding and Exercisable Exercise Price Per Share Shares Life (Years) Weighted Average $ 0.004750 15,800,319 1.883 $ 0.00475

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
INCOME TAXES (Tables)	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Schedule of federal income tax rate and the actual tax rate	Schedule of federal income tax rate and the actual tax rate Year Ended 2021 2020 Federal statutory tax rate 21 % 21 % State tax, net of federal benefit 6 % 6 % Total tax rate 27 % 27 % Allowance ( 27 )% ( 27 )% Effective tax rate - % - %
Summary of deferred tax assets	Summary of deferred tax assets Year Ended 2021 2020 Net operating loss carryforwards $ 3,418,000 $ 3,060,000 Valuation allowance (3,418,000 ) (3,060,000 ) Net deferred tax asset $ - $ -

BUSINESS ACQUISITION (Tables)

BUSINESS ACQUISITION (Tables)	3 Months Ended
BUSINESS ACQUISITION (Tables)	Mar. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of fair value of consideration	Schedule of fair value of consideration Common stock issued, 41,476,963 shares of the Company’s restricted common stock valued at $0.0101 per share $ 418,917 Common stock issuable, 93,523,037 shares of the Company’s restricted common stock valued at $0.0101 per share 944,583 Net liabilities assumed 2,871,066 Earnout liability 7,679,984 Cash paid 1,085,450 Fair value of total consideration paid $ 13,000,000
Schedule of net asset acquired and liabilities assumed	Schedule of net asset acquired and liabilities assumed Cash and cash equivalents $ 107,689 Property 36,882 Total assets 144,571 Accounts payable and accrued liabilities 1,711,349 Notes payable 526,385 Deferred revenue 777,903 Total liabilities $ 3,015,637 Net liabilities assumed $ 2,871,066

CONVERTIBLE NOTES PAYABLE (Tabl

CONVERTIBLE NOTES PAYABLE (Tables)	3 Months Ended	12 Months Ended
CONVERTIBLE NOTES PAYABLE (Tables)	Mar. 31, 2022	Dec. 31, 2021
Debt Disclosure [Abstract]
Schedule of Convertible notes payable	Schedule of Convertible notes payable March 31, December 31, Various Convertible Notes $ 43,500 43,500 Golock Capital, LLC Convertible Notes (a) 339,011 339,011 Other Convertible Notes (b) 256,203 253,203 Total Convertible Notes $ 638,714 635,714	Schedule of Convertible notes payable December 31, December 31, Various Convertible Notes (a) $ 43,500 43,500 Ylimit, LLC Convertible Notes (b) - 1,336,208 Golock Capital, LLC Convertible Notes (c) 339,011 339,011 Other Convertible Notes (d) 253,203 238,203 Total Convertible Notes $ 635,714 1,956,922

ORGANIZATION AND BASIS OF PRE_2

ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	93,523,037
Net cash (used in) operating activities	$ 248,739	$ 174,019			$ 1,430,312	$ 518,493
Accumulated deficit	15,028,400				13,835,294	16,755,676
Negative working capital					2,793,040
Cash	60,458				36,958	4,458
Net loss	$ 1,193,106	$ (1,991,101)			(2,920,382)	4,553,777
Working capital					$ (2,793,040)
Stage It Corp [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Net cash (used in) operating activities			$ 897,425	$ (682,920)		(259,926)	$ 10,506
Accumulated deficit			13,383,161			10,569,502	8,939,994
Negative working capital			(8,988,706)			(6,668,922)
Cash			69,342	749,588		281,003	88,457	$ 98,963
Net loss			2,813,659	$ 617,171		1,629,508	$ 2,456,023
Working capital			8,988,706			6,668,922
Cash on hand			$ 69,342			$ 281,033
Tgri [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	50,762,987				50,762,987

SIGNIFICANT AND CRITICAL ACCO_4

SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES (Details)	3 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of property and equipment	3 years
Office Equipment [Member] \| Stage It Corp [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of property and equipment		3 years		3 years
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of property and equipment	7 years
Furniture and Fixtures [Member] \| Stage It Corp [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of property and equipment		7 years		7 years
Vnue Inc. formerly TGRI [Member]
Property, Plant and Equipment [Line Items]
State of Incorporation			Nevada
Entity Incorporation, Date of Incorporation			Apr. 04, 2006
Attributable interest			100%
Vnue Inc. (Vnue Washington) [Member]
Property, Plant and Equipment [Line Items]
State of Incorporation			Washington
Entity Incorporation, Date of Incorporation			Oct. 16, 2014
Attributable interest			100%
Vnue LLC [Member]
Property, Plant and Equipment [Line Items]
State of Incorporation			Washington
Entity Incorporation, Date of Incorporation			Aug. 01, 2013
Attributable interest			100%

SIGNIFICANT AND CRITICAL ACCO_5

SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Fair value of derivative liabilities					$ 0	$ 3,156,582
Anti-dilutive shares					0
Fair value of derivative liabilities						2,404,981	$ 2,099,025
Depreciation expense	$ 1,880	$ 0
Property and equipment	35,002				$ 0
Deferred Revenue	857,326				$ 74,225	$ 74,225
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Depreciating office equipment	200
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Depreciating office equipment	$ 1,000
Stage It Corp [Member]
Property, Plant and Equipment [Line Items]
Anti-dilutive shares						0
Revenue recognition, description			Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer, however there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production.			Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer, however there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production.
Fair value of derivative liabilities			$ 2,670,162			$ 2,404,981	2,099,025
Depreciation expense			17,767			4,468
Property and equipment			60,303			62,912
Fair value of derivative liabilities			2,670,163			2,404,091
Stage It Corp [Member] \| Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Depreciation expense			200			200
Stage It Corp [Member] \| Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Depreciation expense			1,000			1,000
Stage It Corp [Member] \| Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment			$ 60,303			$ 62,912	$ 0
Three Convertible Notes [Member]
Property, Plant and Equipment [Line Items]
Anti-dilutive shares					11,313,852
Convertible Notes Payables [Member]
Property, Plant and Equipment [Line Items]
Anti-dilutive shares	20,333,526
Warrant [Member]
Property, Plant and Equipment [Line Items]
Anti-dilutive shares	149,489,159				15,800,319

PREPAID EXPENSE (Details Narrat

PREPAID EXPENSE (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
PREPAID EXPENSE (Details Narrative) - USD ($)	Mar. 31, 2022	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2020	Jan. 09, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Prepaid expenses		$ 464,336		$ 100,000
Advanced to affiliate			$ 364,336
Other Prepaid Expense, Current	$ 100,000	$ 464,336			$ 100,000
MT Agreement [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Description of payment	the Company agreed to pay an advance of $100,000 against sales, to MT and its affiliated companies, which was paid in full in installments, with the last installment of $40,000 paid on March 4, 2020.	$100,000 of the prepaid expense in both periods relates to a Jan 9th, 2020 an agreement entered into by the Company with recording and performance artist, Matchbox Twenty “MT Agreement”), to record its 2020 tour and sell limited edition double CD sets, download cards, and digital downloads. As part of the deal, the Company agreed to pay an advance of $100,000 against sales, to MT and its affiliated companies, which was paid in full in installments, with the last installment of $40,000 paid on March 4th.

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Sep. 30, 2021
Related Party Transaction [Line Items]
Revenues	$ 5,049	$ 2,261	$ 100,476	$ 22,474
License cost	252	$ 113	5,024	1,124
Accrued payroll-officers	231,750		$ 233,750	209,750
Forgivness of debt					$ 14,000
Gain on settlement of vendor obligations					14,000
Interest rate			8%
Due to Related Parties, Current			$ 720	$ 720
Two Officers [Member]
Related Party Transaction [Line Items]
Accrued payroll-officers	231,750		233,750
Chief Executive Officers' [Member]
Related Party Transaction [Line Items]
Compensation cost	$ 170,000
Due to Related Parties, Current			10,000
Stage It Corp [Member]
Related Party Transaction [Line Items]
Interest rate				18%		18%
Due to related parties				$ 547,500	547,500	$ 547,500
Accrued interest				767,715	$ 617,891
Accrued interest				$ 767,515		$ 893,632
Chief Executive Officers' [Member]
Related Party Transaction [Line Items]
Compensation cost			$ 170,000

ACCOUNTS PAYABLE AND ACCRUED _3

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) - USD ($)		Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Accounts payable			$ 588,275		$ 587,230
Accrued interest		$ 259,179	189,527		466,801
Accrued interest and penalties Golock			0		1,172,782
Soundstr Obligation		145,529	145,259		145,259
Total accounts payable and accrued liabilities			923,061		2,372,072
Accounts payable					427,086	$ 223,795
Accrued Liabilities	[1],[2]				1,785,861	699,914
Accrued interest					650,654	502,916
Accrued interest- related parties					767,715	617,891
Total accounts payable and accrued liabilities		2,702,948	923,061		2,404,981	2,044,516
Accounts payable and accrued expense		2,298,240	588,275
Total accounts payable and accrued liabilities		$ 2,702,948	$ 923,061		2,404,981	2,044,516
Stage It Corp [Member]
Accounts payable				$ 599,817	427,086
Accrued interest				2,313,671	1,785,861	699,914
Total accounts payable and accrued liabilities				840,197	650,654	$ 502,916
Accrued Liabilities	[3],[4]			2,313,671	1,785,861
Accrued interest				840,197	650,654
Accrued interest- related parties				893,632	767,715
Total accounts payable and accrued liabilities				4,647,317	2,404,981
Total accounts payable and accrued liabilities				$ 4,647,317	$ 2,404,981

[1]Includes $398,729 in liabilities due to artists and $297,795 in unredeemed outstanding notes purchased by users as of December 31, 2019[2]Includes $946,537 in liabilities due to artists and $791,172 in unredeemed outstanding notes purchased by users as of December 31, 2020[3]Includes $887,120 in liabilities due to artists, $846,477 in unredeemed outstanding notes purchased by users, and $376,703 in payroll liabilities as of September 30, 2021[4]Includes $946,537 in liabilities due to artists and $781,172 in unredeemed outstanding notes purchased by users as of December 31, 2020

PURCHASE LIABILITY (Details Nar

PURCHASE LIABILITY (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended		12 Months Ended
PURCHASE LIABILITY (Details Narrative) - USD ($)	Oct. 16, 2018	Oct. 16, 2017	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2018	Dec. 31, 2021
Dividends Payable [Line Items]
Amortized value of intellectual property			$ 108,333
Earnout Liabilities			7,679,984
Dividend Declared [Member]
Dividends Payable [Line Items]
acquisition cost		$ 50,000
Purchase liability		300,000
Purchase price		350,000
Total purchase of intellectual property	$ 350,000
Amortized value of intellectual property	$ 116,668
Impairment charge					$ 204,165
Purchase Liability Net		300,000	$ 7,979,984			$ 300,000
Purchase Price Net		$ 50,000

SHARES TO BE ISSUED (Details Na

SHARES TO BE ISSUED (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
SHARES TO BE ISSUED (Details Narrative) - USD ($)	Mar. 31, 2022	Dec. 31, 2019	Dec. 31, 2021	Dec. 31, 2018
Short-term Debt [Line Items]
Common stock to be issued, shares			5,204,352	3,964,352
Common stock to be issued, value			$ 247,707	$ 243,839
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	93,523,037
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable	$ 944,583
PledgeMusic, Inc. [Member] \| Business Acquisition [Member]
Short-term Debt [Line Items]
Common stock shares issued for amending existing convertible notes, shares		1,000,000
Common stock shares issued for amending existing convertible notes, amount		$ 3,500
Convertible Notes Payable [Member]
Short-term Debt [Line Items]
Common stock shares issued under plan, shares		240,000
Common stock shares issued under plan, amount		$ 184

NOTES PAYABLE (Details Narrativ

NOTES PAYABLE (Details Narrative) - USD ($)	12 Months Ended
NOTES PAYABLE (Details Narrative) - USD ($)	Dec. 31, 2021	Mar. 31, 2022	Dec. 31, 2020
Short-term Debt [Line Items]
Note payable	$ 869,157		$ 34,000
Notes payable	$ 869,157	$ 1,142,542	$ 34,000
Interest rate	8%
Other notes payable	$ 857,157
Interest Payable, Current	12,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability		$ 273,385
Note Payable [Member]
Short-term Debt [Line Items]
Note payable	857,157
Notes payable	$ 12,000

CONVERTIBLE NOTES PAYABLE AND_3

CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE, RELATED PARTIES TO BE UPDATED (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Feb. 02, 2018
Short-term Debt [Line Items]
Convertible notes payable	$ 638,714	$ 635,714	$ 1,956,922
Various Convertible Notes [Member]
Short-term Debt [Line Items]
Total Convertible Notes		43,500	43,500
Ylimit, LLCC convertible Notes [Member]
Short-term Debt [Line Items]
Total Convertible Notes		0	1,336,208
Golock Capital, LLC Convertible Notes [Member]
Short-term Debt [Line Items]
Total Convertible Notes		339,011	339,011	$ 40,000
Other Convertible Notes [Member]
Short-term Debt [Line Items]
Total Convertible Notes		$ 253,203	$ 238,203

CONVERTIBLE NOTES PAYABLE AND_4

CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE, RELATED PARTIES (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended				4 Months Ended	12 Months Ended
	Apr. 29, 2019	Feb. 02, 2018	Mar. 31, 2022		Jun. 30, 2021	Dec. 31, 2019	Dec. 31, 2017	Dec. 31, 2021		Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2018
Short-term Debt [Line Items]
Convertible notes payable			$ 638,714					$ 635,714
Interest rate								8%
Conversion of principal amount					$ 1,162,800
Note payable								$ 869,157			$ 34,000
Conversion of accrued interest					$ 38,616
Shares issued upon conversion of convertible notes payable					75,195,174
Loss on the extinguishment of debt					$ 80,227
Conversion price								$ 0.001
Warrants issued			133,689,840
Exercise price			$ 0.0109			$ 0.079		$ 0.0079		$ 0.079	$ 0.079
Stock price						$ 1.59				$ 1.59	$ 1.59
GHS Investments [Member]
Short-term Debt [Line Items]
Interest rate			8%					8%
Conversion price			$ 0.0171					$ 0.0171
Convertible promissory note								$ 165,000
Beneficial conversion feature								106,765
Golock Capital, LLC Convertible Notes [Member]
Short-term Debt [Line Items]
Convertible notes payable			$ 339,011	[1]				339,011	[1]			$ 302,067
Interest rate		10%					10%
Debt instrument, principal amount		$ 40,000	339,011				$ 191,750	339,011
Maturity date description		November 2, 2018					maturity dates between September 1, 2018 and August 31, 2018.
Debt instrument, description							The notes are convertible into shares of the Company’s common stock at prices between $0.015 and $0.02 per share
Warrants issued							4,804,708
Exercise price		$ 0.015					$ 0.014
Related debt discount		$ 40,000					$ 19,652					$ 0
Debt discount		$ 5,000
Stock price		$ 0.015
Warrant issued to common stock		2,500,000
Increase/decrease in derivative liability		$ 553,000
Financing cost		$ 43,250
Amount of additional penalties and interest			1,172,782					$ 1,172,782
Golock Capital Llc Convertible Note [Member]
Short-term Debt [Line Items]
Debt instrument, description		Company amended the notes above by changing the conversion feature for the aggregate notes to be convertible into shares of common stock of the Company at the lower of (i) $0.015 per share or, (ii) 58% of the lowest closing bid price in the 20 trading days prior to the day that the Lender requests conversion.
YLimit, LLC [Member] \| February 9, 2020 [Member]
Short-term Debt [Line Items]
Shares issued upon conversion of convertible notes payable								874,300,140
Borrowing limit increased										$ 175,000
Fundings								$ 119,000
Golock [Member]
Short-term Debt [Line Items]
Debt instrument, description	They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender request conversion
Golock [Member] \| Amendment [Member]
Short-term Debt [Line Items]
Debt conversion, converted instrument, amount						$ 53,331				53,331
Convertible notes payable						339,010				339,010
Debt instrument, description	They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender requested conversion.
Debt conversion, converted instrument, accured interest										$ 23,102
Debt conversion, converted instrument, shares issued										100,000,000
Notes past due						285,679				$ 285,679
Lender [Member] \| Amendment [Member]
Short-term Debt [Line Items]
Notes past due			$ 73,204					73,204
Officer [Member]
Short-term Debt [Line Items]
Advanced from related party								10,000
Balance due								10,000
Note Payable [Member]
Short-term Debt [Line Items]
Debt conversion, converted instrument, amount								492,528
Convertible notes payable								364,629
Increase in convertible amount								107,000
Conversion of principal amount								857,157
Note payable								857,157
Three Convertible Notes [Member]
Short-term Debt [Line Items]
Convertible notes payable								$ 43,500			$ 43,500
Interest rate								10%
Due to related parties								$ 28,500			$ 28,500
Conversion of notes into common stock								740,251
Three Convertible Notes [Member] \| YLimit, LLC [Member]
Short-term Debt [Line Items]
Convertible notes payable						882,500				$ 882,500
Borrowing limit increased						$ 175,000

[1]On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Lender”) in the principal amount of $

DERIVATIVE LIABILITY (Details)

DERIVATIVE LIABILITY (Details) - USD ($)	9 Months Ended	12 Months Ended
DERIVATIVE LIABILITY (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Derivative [Line Items]
Stock Price			$ 1.59	$ 1.59
Risk-free interest rate			0.10%	2.54%
Expected volatility			94.55%	147.95%
Expected life (in years)			1 year	1 year
Expected dividend yield			0%	0%
Exercise Price			$ 1.19	$ 1.19
Fair Value:			$ 2,404,981	$ 2,099,025
Stage It Corp [Member]
Derivative [Line Items]
Stock Price	$ 1.59		$ 1.59
Risk-free interest rate	0.04%		0.10%
Expected volatility	110.45%		94.55%
Expected life (in years)	1 year		1 year
Expected dividend yield	0%		0%
Exercise Price	$ 1.19		$ 1.19
Fair Value:	$ 2,670,162		$ 2,404,981	$ 2,099,025
Option Pricing Models [Member]
Derivative [Line Items]
Stock Price			$ 0.0114
Risk-free interest rate			0.17%
Expected volatility			737.80%
Expected life (in years)			1 year
Expected dividend yield			0%
Fair Value		$ 0	$ 3,156,582
Minimum [Member] \| Option Pricing Models [Member]
Derivative [Line Items]
Stock Price			$ 0.0015
Maximum [Member] \| Option Pricing Models [Member]
Derivative [Line Items]
Stock Price			$ 0.0018

STOCKHOLDERS DEFICIT (Details)

STOCKHOLDERS DEFICIT (Details) - $ / shares	3 Months Ended	12 Months Ended
STOCKHOLDERS DEFICIT (Details) - $ / shares	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Equity [Abstract]
Number of Warrants Outstanding, Begining Balance		23,805,027	23,805,027	8,004,708
Weighted average exercise price or warrants outstanding, Begining Balance		$ 0.079	$ 0.079	$ 0.014
Warrants granted	133,689,640		0	15,800,319
Weighted average exercise price, Warrants granted	$ 0.01122		$ 0	$ 0.00475
Warrants exercised			0	0
Weighted average exercise price, Warrants exercised			$ 0	$ 0
Warrants expired or forfeited		(8,004,708)		0
Weighted average exercise price, Warrants expired or forfeited		$ 0		$ 0
Number of Warrants Outstanding, Ending Balance		15,800,319
Weighted average exercise price or warrants outstanding and exercisable, Ending Balance		$ 0.0079
Number of Warrants Outstanding, Begining Balance	15,800,319	23,805,027	23,805,027
Weighted average exercise price or warrants outstanding, Begining Balance	$ 0.0079	$ 0.079	$ 0.079
Weighted average exercise price, Warrants expired or forfeited
Number of Warrants Outstanding, Ending Balance	149,489,959	15,800,319	23,805,027	23,805,027
Weighted average exercise price or warrants outstanding and exercisable, Ending Balance	$ 0.0109	$ 0.0079	$ 0.079	$ 0.079

STOCKHOLDERS DEFICIT (Details 1

STOCKHOLDERS DEFICIT (Details 1) - $ / shares	12 Months Ended
STOCKHOLDERS DEFICIT (Details 1) - $ / shares	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Class of Warrant or Right [Line Items]
Exercise price per share		$ 0	$ 0
Number of Warrants, Outstanding and Exercisable	23,805,027	23,805,027	8,004,708
Weighted average exercise price or warrants, Outstanding and Exercisable	$ 0.079	$ 0.079	$ 0.014
Warrant One [Member]
Class of Warrant or Right [Line Items]
Exercise price per share	$ 0.004750
Number of Warrants, Outstanding and Exercisable	15,800,319
Weighted Average Remaining Contractual Life (Years)	1 year 10 months 18 days
Weighted average exercise price or warrants, Outstanding and Exercisable	$ 0.00475

STOCKHOLDERS_ DEFICIT (Details

STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)		1 Months Ended		3 Months Ended	12 Months Ended
STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)	Jan. 03, 2022	May 22, 2020	Jul. 02, 2019	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Sep. 30, 2021	May 22, 2019
Class of Stock [Line Items]
Common stock capitalized			2,000,000,000
Preferred stock, shares authorized					20,000,000	20,000,000
Preferred stock capitalized			5,000,000
Common stock, shares authorized				2,000,000,000	2,000,000,000	2,000,000,000
Common stock, shares par value				$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares issued				1,459,256,460	1,411,799,497	1,211,495,162
Common stock, shares outstanding				1,459,256,460	1,411,799,497	1,211,495,162
Preferred stock, par value					$ 0.0001	$ 0.0001
Preferred stock, shares issued					4,250,579	4,250,579
Preferred stock, shares outstanding					4,250,579	4,250,579
warrants issued				133,689,840
Strike price				$ 0.01122
Weighted-average remaining contractual life				4 years 5 months 1 day
Stage It Corp [Member]
Class of Stock [Line Items]
Common stock, shares authorized						20,000,000	20,000,000	20,000,000
Common stock, shares par value						$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares issued						972,614	972,614	972,614
Common stock, shares outstanding						972,614	972,614	972,614
Preferred stock conversion, description						Each share of preferred stock is convertible to common stock on a 1 for 1 basis
Two Convertible Noteholders [Member]
Class of Stock [Line Items]
warrants issued							15,800,319
Strike price							$ 0.00475
Financing expense							$ 36,533
Weighted-average remaining contractual life					2 years 29 days
Series A Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized			20,000,000		20,000,000	20,000,000
Preferred stock, par value					$ 0.0001	$ 0.0001
Preferred stock, shares issued					4,250,579	4,250,579
Preferred stock, shares outstanding					4,250,579	4,250,579
Preferred stock, designated									4,126,776
Common stock shares converted		50
fair value of the preferred shares							$ 590,129
Non Redeemable Preferred Stock A [Member] \| Stage It Corp [Member]
Class of Stock [Line Items]
Preferred stock, par value						$ 0.0001
Non Redeemable Preferred Stock A 1 [Member] \| Stage It Corp [Member]
Class of Stock [Line Items]
Preferred stock, par value						0.0001
Non Redeemable Preferred Stock A 2 [Member] \| Stage It Corp [Member]
Class of Stock [Line Items]
Preferred stock, par value						0.0001
Non Redeemable Preferred Stock A 3 [Member] \| Stage It Corp [Member]
Class of Stock [Line Items]
Preferred stock, par value						$ 0.0001
Preferred Stock A [Member] \| Stage It Corp [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized						400,000	400,000	400,000
Preferred stock, par value						$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares issued						40,000	40,000	40,000
Preferred stock, shares outstanding						40,000	40,000	40,000
Preferred Stock A 1 [Member] \| Stage It Corp [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized						3,000,000	3,000,000	3,000,000
Preferred stock, par value						$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares issued						246,543	246,543	246,543
Preferred stock, shares outstanding						246,543	246,543	246,543
Preferred Stock A 2 [Member] \| Stage It Corp [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized						2,000,000	2,000,000	2,000,000
Preferred stock, par value						$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares issued						200,000	200,000	200,000
Preferred stock, shares outstanding						200,000	200,000	200,000
Preferred Stock A 3 [Member] \| Stage It Corp [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized						300,000	300,000	300,000
Preferred stock, par value						$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares issued						196,522	196,522	196,522
Preferred stock, shares outstanding						196,522	196,522	196,522
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized				20,000,000	20,000,000
Preferred stock, par value				$ 0.0001	$ 0.0001
Preferred stock, shares issued				4,250,579	4,250,579
Preferred stock, shares outstanding				4,250,579	4,250,579
Series B Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	1,600
Preferred stock, par value	$ 0.0001
Common stock shares converted	1,200
Financing expense	$ 300,000
Stock Issued During Period, Shares, Restricted Stock Award, Gross	1,535
Return Amount	$ 1,500,000
Financing Fees	$ 42,000
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized				1,600	1,600
Preferred stock, par value				$ 0.0001	$ 0.0001
Preferred stock, shares issued				1,535		0
Preferred stock, shares outstanding				1,535	0

COMMITMENT AND CONTINGENCIES (D

COMMITMENT AND CONTINGENCIES (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended	12 Months Ended
COMMITMENT AND CONTINGENCIES (Details Narrative) - USD ($)	Oct. 31, 2015	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Stage It Corp [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Commitments or contingencies				$ 0	$ 0	$ 0
Initial joint venture agreement [Member] \| MRI [Member] \| September 1, 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Terms of joint venture		The initial term of the JV is for nine (6) months and requires the Company to Pay MRI fifty percent (50%) of net revenue every quarter. As of March 31, 2022, no net revenue was generated from the JV.	The initial term of the JV is for nine (6) months and requires the Company to Pay MRI fifty percent (50%) of net revenue every quarter. As of December 31, 2020, no net revenue was generated from the JV.
Artist Agreement [Member] \| I Break Horses [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Description for commission receivable under agreement	Under the terms of the Artist Agreement, the Company shall handle rights clearing and distribution for I Break Horses recordings and receive 30% of the Net Income generated thereby
Description For Commission Receivable Under Agreements	Under the terms of the Artist Agreement, the Company shall handle rights clearing and distribution for I Break Horses recordings and receive 30% of the Net Income generated thereby.

INCOME TAXES (Details)

INCOME TAXES (Details)	12 Months Ended
INCOME TAXES (Details)	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Federal statutory tax rate	21%	21%
State tax, net of federal benefit	6%	6%
Total tax rate	27%	27%
Allowance	27%	27%
Effective tax rate	(0.00%)	(0.00%)

INCOME TAXES (Details 1)

INCOME TAXES (Details 1) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Net operating loss carryforwards	$ 3,418,000	$ 3,060,000
Valuation allowance	(3,418,000)	(3,060,000)
Net deferred tax asset	$ 0	$ 0

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($)	12 Months Ended
INCOME TAXES (Details Narrative) - USD ($)	Dec. 31, 2021	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Net operating loss carry forwards	$ 12,662,000
Operating loss carryforwards, expiration period	through 2032
Unrecognized tax benefits		$ 0

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	1 Months Ended		2 Months Ended	3 Months Ended	12 Months Ended
SUBSEQUENT EVENTS (Details Narrative) - USD ($)	Mar. 17, 2022	Feb. 14, 2022	May 19, 2022	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Subsequent Event [Line Items]
Debt Instrument, Interest Rate During Period					8%
Preferred Stock Description				Company entered a Securities Purchase Agreement with GHS whereby GHS agreed to purchase, Two Hundred and Fifty Thousand Dollars ($250,000) of the Company’s Series B Convertible Preferred Stock in exchange for Two Hundred and Fifty (250) shares of Series B Convertible Preferred Stock.
Stage It Corp [Member]
Subsequent Event [Line Items]
Payments for (Proceeds from) Loans Receivable						$ 700,922
Proceeds from Loans						$ 250,000
Debt Instrument, Interest Rate During Period						15%
Prepaid Advances Amount						$ 35,000
Stage It Corp [Member] \| Forecast [Member]
Subsequent Event [Line Items]
Equity Method Investment, Ownership Percentage		100%
Sale of Stock, Consideration Received on Transaction		$ 10,000,000
Cash		1,500,000
Stage It Corp [Member] \| Restricted Stock [Member] \| Forecast [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Value, Restricted Stock Award, Gross		$ 8,500,000
Stage It Corp [Member] \| Revenue Factoring Agreement [Member]
Subsequent Event [Line Items]
Proceeds from Other Debt						$ 415,922
Subsequent Event [Member]
Subsequent Event [Line Items]
Business Combination, Consideration Transferred	$ 1,414,000
Stock Issued During Period, Shares, Other			15,229,816
Subsequent Event [Member] \| Stage It Corp [Member]
Subsequent Event [Line Items]
Equity Method Investment, Ownership Percentage		100%
Sale of Stock, Consideration Received on Transaction		$ 10,000,000
Cash		1,500,000
Subsequent Event [Member] \| Stage It Corp [Member] \| Restricted Stock [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Value, Restricted Stock Award, Gross		$ 8,500,000

NOTES PAYABLE -PAST DUE (Detail

NOTES PAYABLE -PAST DUE (Details Narrative) - USD ($)	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Short-term Debt [Line Items]
Notes payable	$ 869,157		$ 34,000
Interest rate	8%
Stage It Corp [Member]
Short-term Debt [Line Items]
Notes payable		$ 1,742,422	1,041,500
Due to related party			547,500	$ 547,500
Notes payable			$ 315,000	315,000
Interest rate		18%	18%
Compound interest			10%
Promissory Notes [Member] \| Stage It Corp [Member]
Short-term Debt [Line Items]
Notes payable			$ 179,000	$ 179,000
Convertible Notes Payable [Member] \| Stage It Corp [Member]
Short-term Debt [Line Items]
Due to related party			$ 275,000

NOTES PAYABLE (Details)

NOTES PAYABLE (Details) - USD ($)		Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021		Dec. 31, 2020		Dec. 31, 2019
Notes Payable, Current		$ 1,142,542	$ 869,157			$ 34,000
Total notes payable			$ 869,157			34,000
Stage It Corp [Member]
Notes Payable, Current				$ 879,722	[1]	179,000	[1]	$ 179,000
Convertible Notes Related Party past Due				547,500		547,500
Convertible Notes past Due	[2]			315,000		315,000
Total notes payable				$ 1,742,422		$ 1,041,500

[1]Notes payable are comprised of a note for $179,000 at 15% interest in both period that is past due, a promissory note for $250,000 at 15% interest, advances of $35,000, and $415,922 in loans under the terms of revenue factoring agreement with three different lenders at an average rate of 18%[2]The Company entered into several convertible promissory notes in 2013, 2014 and 2015 with several related parties (see Note 3) and third parties. These notes were issued to fund the early growth of the Company. The notes were issued at 18% interest compound annually and can only convert to common stock upon the occurrence of a qualified funding, which has not occurred

GONING CONCERN (Details Narrati

GONING CONCERN (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
GONING CONCERN (Details Narrative) - USD ($)	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash and Cash Equivalents, at Carrying Value	$ 60,458		$ 36,958	$ 4,458
Net Cash Provided by (Used in) Operating Activities	248,739	$ 174,019	1,430,312	518,493
Retained Earnings (Accumulated Deficit)	15,028,400		$ 13,835,294	$ 16,755,676
Negative Working Capital	$ 14,595,097

BUSINESS ACQUISITION (Details)

BUSINESS ACQUISITION (Details) - V N U E Acquisition [Member]	Feb. 13, 2022 USD ($)
Business Acquisition [Line Items]
Common stock issued, 41,476,963 shares of the Company’s restricted common stock valued at $0.0101 per share	$ 418,917
Common stock issuable, 93,523,037 shares of the Company’s restricted common stock valued at $0.0101 per share	944,583
Net liabilities assumed	2,871,066
Earnout liability	7,679,984
Cash paid	1,085,450
Fair value of total consideration paid	$ 13,000,000

BUSINESS ACQUISITION (Details 1

BUSINESS ACQUISITION (Details 1) - V N U E Acquisition [Member]	Feb. 13, 2022 USD ($)
Business Acquisition [Line Items]
Cash and cash equivalents	$ 107,689
Property	36,882
Total assets	144,571
Accounts payable and accrued liabilities	1,711,349
Notes payable	526,385
Deferred revenue	777,903
Total liabilities	3,015,637
Net liabilities assumed	$ 2,871,066

BUSINESS ACQUISITION (Details N

BUSINESS ACQUISITION (Details Narrative) - V N U E Acquisition [Member] - USD ($)	1 Months Ended
	Feb. 14, 2022	Feb. 13, 2022
Business Acquisition [Line Items]
Stock Issued During Period, Shares, Acquisitions	135,000,000
GoodWill		$ 10,400,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets		$ 2,600,000

INTANGIBLE ASSETS (Details Narr

INTANGIBLE ASSETS (Details Narrative) - USD ($)	3 Months Ended
INTANGIBLE ASSETS (Details Narrative) - USD ($)	Mar. 31, 2022	Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets, Net (Excluding Goodwill)	$ 2,491,677
Amortization of Intangible Assets	108,333
Finite-Lived Intangible Asset, Expected Amortization, Year One	650,000
Finite-Lived Intangible Asset, Expected Amortization, Year Two	866,666
Finite-Lived Intangible Asset, Expected Amortization, Year Three	866,666
Finite-Lived Intangible Asset, Expected Amortization, Year Four	$ 216,668

CONVERTIBLE NOTES PAYABLE (Deta

CONVERTIBLE NOTES PAYABLE (Details) - USD ($)	1 Months Ended	4 Months Ended	12 Months Ended
CONVERTIBLE NOTES PAYABLE (Details) - USD ($)	Feb. 02, 2018	Dec. 31, 2017	Dec. 31, 2021		Mar. 31, 2022		Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Short-term Debt [Line Items]
Total Convertible Notes			$ 635,714		$ 638,714
Debt Instrument, Interest Rate, Stated Percentage			8%
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 0.0079		$ 0.0109		$ 0.079	$ 0.079
Debt Instrument, Convertible, Conversion Price			$ 0.001
GHS Investments [Member]
Short-term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			8%		8%
Notes Issued			$ 165,000
Debt Instrument, Convertible, Conversion Price			$ 0.0171		$ 0.0171
Various Convertible Notes [Member]
Short-term Debt [Line Items]
Total Convertible Notes			$ 43,500		$ 43,500
Debt Instrument, Face Amount			43,500				$ 43,500
Golock Capital, LLC Convertible Notes [Member]
Short-term Debt [Line Items]
Total Convertible Notes			339,011	[1]	339,011	[1]			$ 302,067
Debt Instrument, Face Amount	$ 40,000		339,011				339,011
Debt Instrument, Interest Rate, Stated Percentage	10%	10%
Debt Instrument, Maturity Date, Description	November 2, 2018	maturity dates between September 1, 2018 and August 31, 2018.
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.015	$ 0.014
Sale of Stock, Number of Shares Issued in Transaction	2,500,000
Unamortized note discount	$ 40,000	$ 19,652							$ 0
Debt Instrument, Description		The notes are convertible into shares of the Company’s common stock at prices between $0.015 and $0.02 per share
Increase (Decrease) in Derivative Liabilities	553,000
Debt Issuance Costs, Net	$ 43,250
Other Convertible Notes [Member]
Short-term Debt [Line Items]
Total Convertible Notes			253,203		$ 256,203
Debt Instrument, Face Amount			$ 253,203				$ 238,203
Golock Capital Llc Convertibles Notes [Member]
Short-term Debt [Line Items]
Debt Instrument, Description	Company amended the notes above by changing the conversion feature for the aggregate notes to be convertible into shares of common stock of the Company at the lower of (i) $0.015 per share or, (ii) 58% of the lowest closing bid price in the 20 trading days prior to the day that the Lender requests conversion.

[1]On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Lender”) in the principal amount of $

CONVERTIBLE NOTES PAYABLE (De_2

CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended		4 Months Ended	12 Months Ended
CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)	Apr. 29, 2019	Mar. 31, 2022		Dec. 31, 2017	Dec. 31, 2021		Dec. 31, 2019	Dec. 31, 2018	Feb. 02, 2018
Short-term Debt [Line Items]
Convertible Notes Payable		$ 638,714			$ 635,714
Golock Capital, LLC Convertible Notes [Member]
Short-term Debt [Line Items]
Debt Instrument, Description				The notes are convertible into shares of the Company’s common stock at prices between $0.015 and $0.02 per share
Convertible Notes Payable		339,011	[1]		339,011	[1]		$ 302,067
Debt instrument, principal amount		339,011		$ 191,750	339,011				$ 40,000
Amount of additional penalties and interest		1,172,782			1,172,782
Golock [Member]
Short-term Debt [Line Items]
Debt Instrument, Description	They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender request conversion
Amendment [Member] \| Golock [Member]
Short-term Debt [Line Items]
Debt Instrument, Description	They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender requested conversion.
Debt conversion, converted instrument, amount							$ 53,331
Debt conversion, converted instrument, accured interest							$ 23,102
Debt conversion, converted instrument, shares issued							100,000,000
Convertible Notes Payable							$ 339,010
Notes past due							$ 285,679
Amendment [Member] \| Lender [Member]
Short-term Debt [Line Items]
Notes past due		$ 73,204			$ 73,204

[1]On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Lender”) in the principal amount of $